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Abstract
The characterization of lipids is performed by mass spectrometry based on
structure speciﬁc fragments or by accurate mass measurements of intact
precursor ions. The latter method, termed ’top-down lipidomics’, is due to
its robustness, simplicity and speed a valuable tool for medical research to
elucidate the molecular background of lipid metabolic disorders.
The current thesis aims to improve the established lipidomics methods.
Therefore, a new top-down lipidomics method was introduced that in-
creased the analysis throughput, lipidome coverage and accuracy of quan-
tiﬁcation, compared to previous approaches, by rapid successive acquisition
of high resolution Fourier transform mass spectra in positive and negative
ion modes. Furthermore, the characterization of molecular lipid species
by utilizing high energy collisional dissociation was achieved on Orbitrap
instruments. The mass accuracy of acquired MS/MS spectra increased
the conﬁdence in identiﬁcation for unusual very-long chain polyunsaturated
phosphatidylcholine species and a new lipid class, the maradolipids. Beyond
that, eﬀort was made to enhance the accuracy and comparability of MS/MS
based bottom-up lipidomics data. In this respect, lipids with varying degree
of unsaturation were analyzed and revealed discrete fragmentation proper-
ties.
The technical reﬁned lipidomics methods allowed insight into the lipid com-
position of lipoproteins and changes of the blood plasma induced by aphere-
sis. Lipidomics screening of blood plasma uncovered an altered lipid pattern
in consequence of impaired glucose metabolism and type 2 diabetes. The
lipidomics characterization of islet allowed their quality assessment.
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1Introduction
1.1 Classiﬁcation of lipids
Lipids are organic molecules based on fatty acids (FA), as well as their derivatives and
biosynthetically related compounds (1). They have been divided into eight categories
based on their core structures (2). We will considered:
  FAs are aliphatic monocarboxylic acids (3) varying in their chain structures,
number and position of double bounds and functional groups (reviewed in (4, 5)).
  Glycerolipids (GL) are FA esters of glycerol. The most abundant GL in mam-
malians is triacylglycerol (TAG), the ester of glycerol and three FAs.
  Glycerophospholipids (GPL) have a FA or fatty alcohol (FA-O) bound to sn-
1, a FA to sn-2 and a phosphate derivate in the sn-3 position. Homologues with
a hydroxyl group at sn-2 position are lyso species (6). Furthermore, GPL are
termed ’plasmalogen’ or ’plasmenyl GPL’ when the FA-O at the sn-1 position is
an 1-Z -alkenyl (6). ’Plasmanyl GPL’ bear FA-Os that are saturated at α carbon.
  Sphingolipids (SL) are base on sphingoid structures, mainly sphingosine ((2S,
3R, 4E ) 2-amino-4-octadecene-1,3-diol), sphinganine ((2S, 3R) 2-amino-octadecan-
1,3-diol) or phytosphingosine ((2S, 3S, 4R) 2-aminooctadecan-1,3,4-triol). FA are
bound to the 2-amino group; carbohydrates or phosphate derivatives to the 1-
hydroxyl group (7, 8).
1
1. INTRODUCTION
  Steroids are tetra-cyclic hydrocarbons, derivatives of hexadecahydrocyclopenta[a]-
phenanthren. Chol-ester-5-en-3β-ol (Chol) and its ester (CholE) are in terms of
quantity the major steroids in mammalians (9, 10).
  Saccharolipids contain FA directly linked to the sugar backbone (2).
(VI) - Saccharolipids: 6,6'-O-dipentadecantrehalose
(II) - Glycerolipids: 1,2-didecanoyl-sn-glycerol
(IV) - Sphingolipids: D-glucosyl-ß-1,1' N-lauroyl-D-erythro-sphingosine
(V) - Steroids: Cholesteryl myristate
(I) Fatty acids: linoleic acid
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(III) - Glycerophospholipids: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
Figure 1.1: Representative structures of distinguished lipid categories. – The
core structures are black; variable structures gray highlighted.
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1.2 Instrumentation for shotgun lipidomics
The ordinary combination of the FAs and the core structures allows to generate
several thousand lipid species with distinct physico-chemical properties and speciﬁc
functions (11, 12). The complement of lipids comprised by cells, tissues or organisms
is thereby referred to as ’lipidome’ and the discipline aiming at its characterization, by
analogy to other ’omics’ sciences, ’lipidomics’ (11). Latest mass spectrometric methods
provide thereby sensitivity and speciﬁcity to analyze the lipidome in unprecedented
detail and allow so to understand processes of the lipid metabolism, the regulation of the
lipid diversity, their function in divers cellular mechanisms as well as their signiﬁcance
for the development of diseases (13).
1.2 Instrumentation for shotgun lipidomics
The layout of the shotgun lipidomics approach is akin to other MS methods and com-
prises: (I) the generation of analyte ions, (II) their separation by mass-to-charge ratio
(m/z ) and (III) the detection in a quantitative manner (14). Characteristic for this
approach is, that the lipids are directly ionized from total extracts by nano- or elec-
trospray ionization (nESI or ESI). The discrimination of the ions is achieved by mass
spectrometry only, a preseparation, as commonly performed by liquid chromatography
(LC), is not stringently required (15).
The shotgun lipidomics approach allows comparably fast, yet speciﬁc and sensitive,
analysis of lipids (16). The robustness of the instrumentation, their ease of use and
the possibility of full automation furthermore beacon, that the approach is optimal for
applications with a large sample size (17, 18).
1.2.1 Electrospray ionization of lipids
The ionization of the lipid analytes for MS analysis is achieved by soft ionization tech-
niques such as ESI and nESI. These techniques are of superﬁcial interest since they
allow the analysis of analytes ensuing from their intact form (15).
During nESI, the analyte mixture is dictated through a capillary with a diameter
smaller then 10  m by electrospray process at a ﬂow rate of 10 to 100 nl/min which
leads to small droplets of about 100 nm. This droplets undergo a subsequent series of
ﬁssions until the analyte molecules convert to gas-phase solute ions (19, 20).
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The formation of molecular or adducts ions of lipid analytes in nESI depends on
the ionization polarity (as reviewed in (21, 22)). Accordingly, the limit of detection
(LOD) for each lipid class depends on the experimental conditions and is e.g. for GPLs
generally one order of magnitude lower in MS(+) compared to MS(−), with exception
of phosphatidylcholine (PC) (23). Important is furthermore, that variations of the
degree of unsaturation (22) or the length of the FA moieties (Figure 1.2B) do not alter
the ionization properties.
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Figure 1.2: Schematic nESI process and observed detector response upon in-
fusion of diﬀerent saturated TAG species. – (A) Schema of nESI process showing
a nozzle of the nano-fabricated ESI chip. The situation is representative for the nega-
tive mode (adapted from (21)). (B) Relative detector response for an analytical standard
containing 5 saturated TAG species of distinct m/z ; of equal weight percentage. TAGs
were measured as [M+NH4]
+
via direct infusion on the LTQ Orbitrap XL. The signals of
isotopic clusters were summed up for each species and divided by their molarity to yield
the detector response (counts/ M). The response of all TAG species was normalized for
TAG 24:0 (m/z 488.3942).
1.2.2 Hybrid tandem mass spectrometry
Mass spectrometric speciﬁcation of the analyte ions is achieved in shotgun lipidomics
by tandem or hybrid tandem instruments (13, 15). In contrast to plain tandem possess
hybrid tandem instruments diﬀerent mass analyzers. This concept allowed the devel-
opment of powerful MS instruments capable of ion isolation as well as highly speciﬁc
and sensitive MS detection (24).
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1.2.2.1 Structure and function of quadrupole devices
The possibility to conduct and isolate ions is an essential function of hybrid tandem
instruments. The device capable to realize this is the quadrupole. It consists of four
rods in a squared conﬁguration (25). Voltages applied to neighboring rods are of the
same value but opposite sign and comprise an alternating (UAC) and a direct current
(UDC) component.
U = UDC + UAC cosωt (1.1)
where ω is the frequency and t the time. Mass selective scanning of the quadrupole
is performed at constant UDC/UAC ratio.
Ions entering the quadrupole mass ﬁlter have two options: (I) They have instable
trajectories, consequent of the applied voltages, and collide after a number of oscil-
lations with the electrodes. (II) Ions on stable trajectories can pass the quadrupole
(Figure 1.3). The quantity of ions transmitting the quadrupole is proportional to the
resolution (25). Reducing the UDC/UAC ratio reduces the resolution of the quadrupole
but enables the transmission of a wide m/z range of ions through the quadrupole. This
capability is utilized for ion guide devices. Also important, quadrupoles are transparent
for uncharged molecules, atoms (such as gases) and clusters.
Progression of the quadrupole led to the invention of quadrupole ion traps, such as
the LTQ. Hereinafter utilized LTQ devices consist of quadrupoles divided into three
segments that have the same voltage applied plus a temporal distinct UDC at the front
and the end segment (27). At the beginning of the trapping, ions enter the rf ﬁeld of
the middle section and are stopped by the potential generated at the end section (14).
The injection period can last for several 10−3 to 100 seconds. Final trapping of a ion
population is achieved by generating a potential also at the front section.
Trapped ions of a deﬁned m/z range can be isolated and analyzed using (I) the tan-
dem in-time MS approach by which ion isolation, ion trap collision induced dissociation
(CID) and mass selective scan out are performed in the same device using resonance
excitation (27) or (II) the tandem in-space MS approach whereas an ion population is
isolated, ejected and further fragmentation and/or detected by another mass analyzer.
For structural elucidation of analytes their dissociation is induced upon increase of
the internal energy after collision with a neutral gases in quadrupole devices. Eﬃcient
5
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and optics
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Figure 1.3: Schema of a quadrupole mass ﬁlter. – Ions emitted from an ion source
enter the quadrupole mass ﬁlter, are separated according to their m/z and detected, if they
have stable trajectories (red). Ions with unstable trajectories (blue) are not transmitted
by the quadrupole. Adapted from (26).
fragmentation is achieved by passing ions through a dense gas (3 to 5 mbar in case of
higher energy collisional dissociation (HCD)) in a rf ﬁeld, or by acceleration of ions
at reduced pressure (10−3 mbar) as performed in case of ion trap CID and pulsed-q
collision induced dissociation (PQD) by LTQ.
1.2.2.2 Orbitrap hybrid tandem mass spectrometer
The previously described quadrupole devices are integral part of hybrid tandem Orbi-
trap instruments of which the LTQ Orbitrap XL, Velos (Figure 1.4) and the QExactive
have been used for experiments. The conceptional diﬀerence of this instruments is that
tandem MS is enabled by LTQ or a standard quadrupole as in the QExactive. Prior
to MS analysis by the Orbitrap, the selected ions or corresponding fragments have to
be trapped in the C-trap (a quadrupole ion trap), since this mass analyzer is pulsed
operating. Once trapped, ions are injected into the Orbitrap by orthogonal ejection
from C-trap with a high energy pulse (28). The acting potentials in the Orbitrap force
the ions to rotate around the spindle like central electrode and to oscillate harmonically
along the x-axis with a frequency ωx that is inverse proportional to their m/z
6
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ωx =
√
k
z
m
(1.2)
where ωx is the frequency of a current I induced in the outer electrodes by N ions
oscillating with an amplitude of Δx (29).
I(t) ∝ NωxΔx sin (ωxt) (1.3)
The resolving power R depends on the resolution of the frequencies of axial oscilla-
tions ωx with
R =
m
Δm
=
1
2
ωx
Δωx
(1.4)
Precise ion injection and a high vacuum of 10−10 mbar are required to achieve high
performance of the Orbitrap (30).
Ion optic segments
S-lens Quadrupole Octapole High pressure IT Low pressure IT Multipole C-trap HCD collision cell
Precursor isolation
Fragmentation
Mass detection
I
II
III
I II III II
IIIto vacuum pumps
Figure 1.4: The structure of a LTQ Orbitrap Velos. – The illustration shows the
main components: The dual-linear ion trap quadrupoles (LTQ Velos) that comprises two
LTQ of high (6.7 × 10−3 mbar) and low (4.7 × 10−4 mbar) helium pressure. The curved
ion trap (C-trap) with attached HCD collision cell and the high resolution mass analyzer,
the Orbitrap. Ions are guided from the ambient (103 mbar) to low pressure and between
segments by rf only multipole ion guides (faded out).
The resolution, mass accuracy and acquisition speed, provided by the Orbitrap
are the most important vantages of this analyzer. High mass accuracy and resolution
in particular help to overcome the uncertainty, low speciﬁcity of low resolution mass
spectrometry. On the LTQ Orbitrap Velos, a m/z range from 100 to 2000 can be
measured in 1.3 s at a targeted resolution R m/z 400 130.000
1.
1The resolution of the Orbitrap analyzer declines proportionally to m/z−0.5.
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1.3 Identiﬁcation and quantiﬁcation of lipids
Lipids can be characterized by mass spectrometry in two ways: (I) by ’bottom-up
lipidomics’ using structure-speciﬁc fragments, as reviewed in (21), which provides in-
formations about individual molecular lipid species, and (II) by ’top-down lipidomics’
utilizing accurate mass measurements of the intact lipid precursors as reviewed in (31).
1.3.1 Identiﬁcation of lipids by bottom-up approach
Lipids consist of class and species speciﬁc structures such as the head group and the
FA moieties. Upon CID, these structural units lead to speciﬁc fragment ions with
which lipidomes can be analyzed systematically (reviewed in (15, 23)). Initially, such
experiments were performed on triple quadrupole (QqQ) instruments using diﬀerent
acquisition methods (Figure 1.5).
In precursor ion scanning (PIS), the ﬁrst mass analyzer scans a user-speciﬁed m/z
range (m1 to mx). The precursor ions are fragmented subsequently and a deﬁned
product ion is detected. In this way lipid class fragments or the species speciﬁc car-
boxyl anions are analyzed (21). For example, the phosphocholine cation is detected
speciﬁcally for phosphatidylcholine (PC) and sphingomyelin (SM) species by PIS 184
(calc. m/z 184.07332) in positive acquisition mode (Figure 1.6). In negative mode
phosphatidylinositol (PI) species can be monitored by PIS 241 (calc. m/z 241.01188).
Similarly, carboxylate anions released from GPLs, e.g. [FA 18:0 − H]− and [FA 18:1 −
H]−, can be monitored by PIS or fatty acid scanning (FAS) 283 (calc. m/z 283.26425)
and PIS/FAS 281 (calc. m/z 281.24860) (Figure 1.6).
Neutral loss scanning (NLS) is performed by scanning of a user-speciﬁed m/z range
(m1 to mx) by the ﬁrst mass analyzer. Subsequently generated fragments are detected
if a speciﬁed mass oﬀset (nl) corresponds to the neutral loss (NL) (m1 − nl, m2 − nl,
etc.). Similar to PIS, class and species speciﬁc fragments can be detected, e.g. phos-
phatidylethanolamine (PE) species are monitored by NLS 141 (calc. m/z 141.01909)
in positive acquisition mode.
The analysis of all generated fragments is achieved by product ion scanning. Here,
the ﬁrst mass analyzer selects one precursor ion that is subsequently fragmented. The
second mass analyzer is scanning such that all fragments are detected according to their
m/z.
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Another tandem MS/MS mode is the selected reaction monitoring (SRM). In this
case, both, the precursor and the fragment ion of interest are preselected. The fragment
of one speciﬁed precursor will be detected. SRM is used to perform targeted lipidomics
experiments, which focus on preselected lipid analytes (15).
C Product ion scan
A Precursor ion scan
B Neutral loss scan
Precursor ion
scan / isolation Fragmentation
m1
m2
m3
m4
m1
m2
m3
m4
m1 - nl
m2 - nl
m3 - nl
m4 - nl
p
m
m - nl
p1
p2
Fragment ion
isolation / scan
D Selected reaction
     monitoring
m p
p
p
p
Figure 1.5: Tandem MS modes used for lipid analyses. – Events of precursor ion
isolation; fragmentation and fragment isolation are segregated in-time or in-space. (A)
Precursor ion scanning (PIS): precursors (m1 to m4) are scanned according to their m/z.
Only fragment ions (p) of a speciﬁc m/z are detected. (B) Neutral loss scanning (NLS):
precursors (m1 to m4) are scanned according to their m/z. Product ions with a speciﬁc
mass oﬀset/neutral loss (nl) of m/z mx − nl are detected. (C) Production ion scanning:
one precursor (m) is selected and subjected to fragmentation. The generated fragment
and product ions are scanned/detected according to their m/z. (D) Selected reaction
monitoring: one product (p) is monitored for a speciﬁc precursor (m). Adapted from (15).
The performance of precursor and product ion as well as neutral loss scans was sim-
pliﬁed and accelerated by the introduction of hybrid tandem mass spectrometer since
e.g. Orbitrap and time-of-ﬂight (TOF) mass analyzer allowed the simultaneous detect
of fragments. This capability was utilized for bottom-up lipidomics by multiple precur-
sor ion scanning (MPIS) where user-speciﬁed lipid species and class speciﬁc fragments
are measured simultaneously (Figure 1.6) (32).
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Figure 1.6: Identiﬁcation of lipid species by multiple precursor and fatty acid
scanning – (A) Lipids are characterized in bottom-up lipidomics experiments based on
lipid species and class speciﬁc fragments. Upon fragmentation of PC-O 16:1/18:2 the lipid
class speciﬁc phosphocholine cation can be detected by PIS 184.07. In negative acquisition
mode is a class speciﬁc NL of 60.02 Th and the species speciﬁc carboxylate anion FA 18:2
are detectable. (B) By PIS 184.07 all lipid species with choline head group are detected.
(C) Molecular lipid species are detected by PIS for carboxylate anions. (B) and (C) were
adopted from (32).
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An alternative bottom-up approach that also uses the option of simultaneous frag-
ment detection is the data dependent acquisition (DDA). MS/MS spectra are thereby
acquired depending on the intensity of the precursor ions in MS (33, 34). The MS/MS
spectra comprises all fragments. However, it will only be acquired if there is a precur-
sor ion which matches the user-speciﬁed selection criteria. Neither the m/z range of
precursor nor the fragment ions need to be speciﬁed. This makes the DDA not only
valuable for rapid monitoring of molecular lipid species in samples but also for studying
of unknown lipids as demonstrate in (35).
Apart from the speciﬁcity, the recovery of a certain fragment should be known
to allow valid absolute quantiﬁcation by bottom-up lipidomics. By now, quantitative
fragmentation data are available only to a limited extent.
1.3.2 Top-down lipidomics by accurate mass measurements
Molecular or adduct ions of diﬀerent lipid classes have distinct heteroatomic composi-
tions 1 and therefore, they have distinguishable exact masses at adequate high resolution
when they are peak base resolved (Figure 1.7 A). Lipid species of the same class have
the identical number of heteroatoms but diﬀer in the number of hydrogen and carbon
atoms.
Currently available mass analyzers, such as the Orbitrap, enable high resolution
and accurate mass measurements in MS, MS/MS or MSn. The mass resolution of 1 ×
105 (FWHM) allows the distinction of lipid analytes with unique molecular formulas
and the mass accuracy increases the conﬁdence in identiﬁcation (14, 31).
At a mass resolution below 1.5 × 105 (FWHM) the monoisotopic peak of a species,
having the molecular formula CxHy . . ., is not resolved from the ’second’ isotope of
a species with the molecular formula CxHy−2 . . . (Figure 1.7 B). The mixed signal
measured for both is a ’pseudomonoisotopic’ peak. This overlap has to be considered
for the identiﬁcation, because this eﬀects the mass accuracy, but particularly for the
quantiﬁcation of lipid species (Section 1.3.3). Only at a mass resolution of more than
1.5 × 105 (FWHM) the monoisotopic and the isotopic peaks are suﬃciently resolved
(Figure 1.7 C).
1Hetero atoms are atoms e.g. of the element phosphor, nitrogen, oxygen. Carbon and hydrogen do
not belong to this group.
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Figure 1.7: High resolution mass spectrometry lipid analysis. – (A) PE-O
16:0p/22:6 and PE 18:0/18:0 are resolved at R of 100.000 (FWHM) (red line). Both
species become quasi isobaric at low resolution of 7.500 (FWHM). Then, they can not be
unequivocally assigned. (B) FT MS of a 100:7 (n:n) mixture of PE 18:0/18:2 (0.5  M, [M −
H]−, calc. m/z 742.53923) and PE 18:0/18:1 (0.035  M, [M − H]−, calc. m/z 744.55488)
was measured via direct infusion on the LTQ Orbitrap Velos. (C) HCD FT MS/MS of
m/z 744.4. FA 18:1 was resolved from the ’second’ isotope of FA 18:2. Targeted resolution
R m/z 400 was 130.000 (FHWM) for FT MS and FT MS/MS. The local resolution was as
indicated.
An advantage of the top-down lipidomics approach is that in contrast to the bottom-
up strategy, the lipid analysis does not depend on the fragmentation properties of the
analytes. Furthermore, high resolution ’survey scanning’ of lipids by FT MS is much
faster than the MS/MS analysis of multiple lipid species. For comparison, the complete
bottom-up analysis of one extract might take 30 to 90 min, while MS only screening
takes 3 to 5 min (31). Thus, a much greater number of samples can be ’screened’ in
a certain time frame for lipidomics changes. Clusters of molecular lipid species of the
same m/z are thereby treated as a sum of the single components (Section 5.2 for lipid
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annotation).
Until now clinical lipidomics screens were performed predominantly in one acquisi-
tion polarity only (18). As a consequence, the characterization of certain lipid classes
could not be achieved.
1.3.3 Quantiﬁcation of lipids
The identiﬁcation of lipids by bottom-up and top-down approach was introduced. The
detected intensities in this experiments have to be corrected in order to achieve valid
quantiﬁcation.
First, the overlap of isotopes leading to pseudomonoisotopic peaks in complex mix-
tures at a resolution below 1.5 × 105 (FWHM) has to be considered. With the ’type II
correction’ the intensity of pseudomonoisotopic peaks is subtracted by the calculated
intensity of an overlapping second isotope to give the intensity of the actual monoiso-
topic peak. In our example (Figure 1.8B): the second isotope of PC 36:3 overlaps with
the monoisotope of PC 36:2. The type II correction provides the true intensity of PC
36:2.
Second, the intensities of all detected lipids, including the corresponding internal
standards, have to be corrected for the distinct isotopic abundances (Figure 1.8B). This
is the ’type I correction’. The correction factor equals the ratio of the sum of all isotopic
peaks of a species divided by the monoisotopic peak.
Only after type I and type II correction we can compare the intensities, if there are
no other disturbance variables, and quantify lipid species (Figure 1.8C).
The concentration of a corresponding lipid species (cA) is ﬁnally determined from
the ratio of its intensity (IA) respective to the intensity of the internal standard (IIS),
for which we know the concentration (cIS). Commonly, bottom-up and top-down
lipidomics approaches employ one internal standard per lipid class (17, 21).
cA =
IA
IIS
∗ cIS (1.5)
Note: Internal standards have to be added to the sample prior to the extraction to
compensate for lipid class speciﬁc eﬀects during the lipidomics experiment. The m/z
of the internal standard should be preferably distinct from the endogenous species.
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The application of one standard per class is an ample simpliﬁcation. Yet, the opposite
approach, the utilization of one standard per lipid analyte is technically hardly feasible.
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Figure 1.8: The impact of isotopic correction I and II. – (A), (B) and (C) are
computed spectra of lipid species PC 13:0/13:0 (m/z 694.46646), PC 18:0/18:3 (m/z
828.57601), PC 18:0/18:2 (m/z 830.59166), PC 18:0/18:1 (m/z 832.60731), PC 18:0/18:0
(m/z 834.62296), PC 23:0/23:0 (m/z 974.77946) (all [M + HCOO]−) with a proportion
of 1:0.5:0.75:1:0.5:1. Spectra (A) represents a high resolution MS spectra (R m/z 400 of
130.000) as it would be obtained for a corresponding mixture by nESI FT MS on a LTQ
Orbitrap instrument. (B) and (C) represent the situation after type II and subsequent
type I isotopic correction.
14
1.4 Investigation of lipid metabolic disorders by mass spectrometry
1.3.4 Lipidomics data analysis by LipidXplorer software
The characterization of lipids from ample MS and MS/MS spectra requires functional
analysis software. The software should be able (I) to read out MS and MS/MS spectra,
(II) to identify lipids, (III) to perform isotopic correction for quantiﬁcation, and (IV)
to process in batch-mode for larger studies. These aspects are suﬃciently fulﬁlled by
LipidProﬁler or LipidView (from ABSciex) and the in-house developed LipidXplorer
software (reviewed in (36)). LipidProﬁler or LipidView are exclusively applicable for
spectra acquired on instruments of the same manufacturer. In contrast, LipidXplorer
is compatible to data formats of diﬀerent manufacturers and includes also the analysis
of high resolution spectra that are generated by Orbitrap mass spectrometer (36).
MS data have to be converted to generic data ﬁle formats, such as mzXML, prior
to processing by LipidXplorer software. The entire data set is then reduced to a single
ﬂat ﬁle database, termed ’Masterscan’, that contains the essential spectra information,
m/z and intensity of each sample (36). The quantity of information is thereby governed
by user-speciﬁed settings including the resolution, mass accuracy, minimum signal in-
tensity et cetera. The lipid identiﬁcation from the ’Masterscan’ is performed by lipid
class speciﬁc MFQL queries that check for plausible lipid masses at MS and/or MS/MS
level (Figure 1.9). Subsequent to the identiﬁcation, the intensity of the lipid species is
corrected for type I and II isotopic eﬀects. Finally, a user-speciﬁc output is generated
which comprised e.g. the identity of a lipid species, its m/z (*.mass), mass accuracy
(*.errppm) and the corrected intensity (*.intensity). Note: as yet, LipidXplorer does
not provide fully automatic absolute quantiﬁcation.
1.4 Investigation of lipid metabolic disorders by mass spec-
trometry
Before the introduction of hybrid tandem MS to lipidomics, the lipid analysis was
restricted by the analytical capabilities of the common methods, e.g. thin layer chro-
matography (TLC), gas chromatography MS (GC/MS) or colorimetric assays. They
allowed to specify integral indices; the lipid class, FA composition or the total Chol
and TAG content. Now we are technically able to characterize, quickly, even individual
lipid species from smallest sample amounts in large scale experiments. Thus, we can
gather the lipidome in its entire complexity.
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QUERYNAME = Phosphatidylethanolamine;
DEFINE prPE = 'C[33..49] H[50..100] O[8] N[1] P[1]'
WITH DBR = (2.5,9.5), CHG = -1; 
DEFINE FA1= 'C[12..22] H[20..50] O[2]'WITH DBR = (1.5,7.5), CHG = -1;
DEFINE FA2= 'C[12..22] H[20..50] O[2]' WITH DBR = (1.5,7.5), CHG = -1;
IDENTIFY 
prPE IN MS1- AND
FA1IN MS2- AND
FA2IN MS2-
SUCHTHAT
FA1.chemsc + FA2.chemsc + 'C5 H11 O4 N1 P1' == PR.chemsc 
REPORT 
MASS = PR.mass;
CHEMSC = PR.chemsc;
ERROR = "%2.2fppm" % "(PR.errppm)";
SPECIES = PE %d:%d / %d:%d" % (FA1.chemsc[C], 
        FA1.chemsc[db] - 1.5, FA2.chemsc[C], FA2.chemsc[db] - 1.5);
FASINTENS = sumIntensity(FA1.intensity, FA2.intensity);;
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Figure 1.9: MFQL query for identifying molecular PE species in DDA data –
The anion of the intact PE is detected in the ’survey’ MS spectrum (termed MS1-) at m/z
702.5 and triggers the acquisition of its MS/MS spectrum (termed MS2-). The MS/MS
spectrum shows the carboxylate anions for FA 16:0 and 17:1 at m/z 255.2 and 267.2,
respectively. During a DDA experiment all peaks of plausible or requested precursors will
be fragmented. To identify e.g. PE molecules in the acquired MS and MS/MS data, we
ﬁrst DEFINE chemical formula constraints for the intact PE molecules (prPE) and the
speciﬁc carboxylate anion fragments (FA1 and FA2). We expect them to be singly charged
(CHG = -1). The allowed unsaturation of the molecular and the carboxylate anions is
expressed by the double bond equivalent range (DBR) and should be, in this case, within
1.5 to 7.5. Next, previously DEFINE(d) precursors are IDENTIF(ed) in MS1- spectrum;
fragments in the corresponding MS2- spectra. Further, the chemical formula of both FA
moieties (FA1.chemsc and FA2.chemsc), together with the PE head group plus the glycerol
backbone should be equal to that of the intact precursor (PR.chemsc), as deﬁned in the
SUCHTHAT section. Finally, the REPORT section describes the data output format,
which can be speciﬁed by the user. Adapted from (37).
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1.4 Investigation of lipid metabolic disorders by mass spectrometry
The propellent question is, how individual lipid species are involved in the metabolic
homeostasis and the pathogenesis of diseases. Following, two representative studies are
introduced to elucidate the power of current lipidomics approaches in investigating
phenomena of lipid metabolic disorders.
  By application of direct infusion tandem MS lipidomics changes in (CHO-K1)
cells, which were exposed to excess palmitic acid (FA 16:0), were monitored (38).
This phenomenon, termed ’lipotoxicity’ (39), is one component of the complex
metabolic disorders type 2 diabetes (T2D).
In this in-vitro experiment FA 16:0 was found to be particularly integrated into
the storage lipid TAG. Yet, FA 16:0 was also detected in membrane lipids such
as PC causing a substantial increase of the saturation. By this, the structure and
integrity of the endoplasmatic reticulum was aﬀected, which, together with the
FA excess, induced oxidative stress triggered apoptosis.
All major lipid classes, including low abundant ceramides (Cer), and molecular
lipid species were quantiﬁed here employing one method. The reported informa-
tion would have been accessible by TLC, followed by derivatization of hydrolyzed
FA and their analysis by GC/MS too. Yet, this procedure would require much
more aﬀord.
  By an LC-MS lipidomics approach information about pre-autoimmune alterations
in the serum lipid composition of children who progressed to type 1 diabetes
(T1D) was achieved. The individuals had reduced serum levels of phosphatidyl-
choline at birth and reduced TAG and potentially antioxidant ether lipid levels
through the follow up (40). Furthermore, species of proinﬂammatory LPC were
increased (at an age of 9 to 18 months by 50 %, within succeeding 9 months by
30 %) in the serum of these individuals before autoantibodies became detectable.
Again, the sensitivity of current lipidomics methods is demonstrated. Lipid
species of high and low abundant classes were accessed. Yet, here we have an
example where the disturbances of the lipid metabolism and the alteration of low
abundant ether- and lyso-PCs levels is associated with a profound change of the
state of health.
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Concerning the reported quantitative data in the literature, it should be noted that
the variation within living organisms are often rather small: below 100 %. Therefore,
precision of lipidomics methods is required. Furthermore, issues of metabolic disorders
have been addressed using diﬀerent lipidomics approaches (reviewed in (15, 41)). Oc-
casionally the delivered data are, in terms of concentration, only partially coincident.
But they should be stringently consistent to allow their comparison and the exchange
of knowledge.
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2Aim of the thesis
Research and diagnostics require the competence to achieve complete and accurate
quantitative data for the precise characterization e.g. of cellulare processes and patho-
genetic phenomena. Beyond that, medical sciences request simplicity and speed from
analytical methods to accomplish large sample sets.
Starting from the previously established bottom-up and top-down lipidomics ap-
proaches it was one aim of the thesis, ﬁrst of all, to elaborate analytical challenges:
1. The integrity and accuracy of top-down lipidomics blood plasma screens.
2. The validity of bottum-up lipidomics on Orbitrap hybrid tandem instruments to
access molecular lipid species for lipidomics screens.
3. The quantitative description of the GPL fragmentation to enhance the analyti-
cal precision and consistency absolute quantitative lipidomcis data of bottom-up
lipidomics data. Particular of interest were thereby antioxidative, polyunsatur-
ated lipid species.
Finally, the reﬁned methods should be used to investigate disorders of the lipid
metabolism with enhanced detail. We addressed:
1. The eﬀect of apheresis treatment on the blood plasma lipids in patients.
2. The connection of impaired glucose metabolism and plasma lipid levels in man.
3. The quality assessment of pancreatic islets to increase the chance of a positive
transplantation outcome.
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3Results and discussion
3.1 Top-down lipidomics on LTQ Orbitrap mass spectro-
meters by successive switching of the acquisition po-
larity
Up to now, lipidomics screens have been performed on the LTQ Orbitrap in one sin-
gle polarity as a compromise of speed and lipid class coverage (18). The method fails
thereby to cover several lipid classes as a consequence of inconvenient ionization condi-
tions. For that reason, I designed a new method that enables the successive acquisition
of high resolution MS spectra of both modes while maintaining sub-ppm mass accuracy.
In this way lipid species and class coverage should be enhanced.
3.1.1 Automated switching of the acquisition polarity
The automatic, successive acquisition of FT MS spectra of positive and negative mode
from one sample was technically enabled by modiﬁcation of the controller of the TriVersa
NanoMate ion source. With this, the spraying voltage polarity could be switched dur-
ing an infusion experiment by the contact closure signal produced from the Orbitrap
instrument. When the status of the relay was set to ’close’ the polarity of the spraying
voltage was changed to positive, regardless of the actual voltage set in the acquisition
method of the Chipsoft software that controls the ion source. The XCalibur MS method
ﬁle consisted of two segments, one for negative and one for positive FT MS acquisitions.
Both acquisitions had to use the same LTQ tune ﬁle. The contact closure was set to
’open’ status in the ﬁrst segment and to ’close’ status in the second (Figure 3.1).
21
3. RESULTS AND DISCUSSION
-70
-60
-50
-40
-30
-20
-10
0
10
20
30
40
50
60
70
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0
C
ur
re
nt
 (n
A
)
Time (min)
NanoMate method
Spray Voltage: - 1.25 kV
Pressure: 0.95 psi
Spray Voltage: + 1.25 kV
Pressure: 0.95 psi
Segment 1
FT MS(-), R m/z 400 = 130,000,
 lock mass engaged
Segment 2
LTQ Orbitrap XL acquisition method
FT MS(+), R m/z 400 = 130,000,
 lock mass engaged
LTQ Orbitrap relay status
Open Close
+_
Figure 3.1: Structure of a lipidomics experiments with alternating spraying
voltage and acquisition polarity. – From top to bottom: (I) LTQ Orbitrap method
was build of two segments one for negative and positive mode separately, but using the
same tune ﬁle. (II) The relay status of the LTQ Orbitrap was set to ’open’ in the ﬁrst
segment and to ’close’ in the second segment whereat the spraying voltage switched to
+1.25 kV on the modiﬁed TriVersa NanoMate electronics platform. (III) One acquisition
method with standard negative mode settings was used by the TriVersa NanoMate for
the complete acquisition. The contact closure signal only changed the voltage polarity
applied to the spraying chip. Both, the value of the voltage and the gas back pressure
remain unchanged. (IV) A representative proﬁle of the nESI current observed in this type
of experiments.
The start of FT MS acquisition by the Orbitrap instrument was initiated by con-
tact closure signal from the ion source. Sample infusion and FT MS acquisition were
temporally synchronized. In the ﬁrst segment, FT MS(−) spectra were acquired by
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electrospraying the sample at −1.25 kV for 3.49 min. Then, the contact closure sig-
nal of the LTQ Orbitrap XL changed the spraying voltage of the ion source to +1.25
kV, bypassing the polarity settings at the Chipsoft software. Subsequently, FT MS(+)
spectra were acquired for 3.5 min. The sample infusion and the acquisition cycle ended
at 7.05 min.
In the described experiment only 1.1  l of the diluted total lipid extract were con-
sumed, which is about 11 % of the delivered sample. The remaining sample could be
used to elaborate details of the lipid composition of a sample via DDA of FT MS/MS.
Stable spraying conditions for up to 50 min with a variation of the total ion current
(TIC) below 20 % were also achieved in dual-polarity experiments (Figure 3.2).
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Figure 3.2: Extended stability of nanoelectrospray supported by nanoﬂow
robotic ion source TriVersa NanoMate. – A total lipid extract of bovine heart was di-
rectly infusion into LTQ Orbitrap XL for 50 min whereas the spraying voltage was changed
from −1.25 kV to +1.25 kV at 25 min. The total ion current varied by 17.8 % and 17.7 %
in negative and positive acquistion mode, respectively.
3.1.2 Identiﬁcation of lock masses for shotgun lipidomics
Switching of the acquisition polarity degrades the mass accuracy on LTQ Orbitrap
instruments because of the temporarily unstable operation of the power supplies. I
observed that it takes more than 60 min to settle it back to the low-ppm level, making
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frequent polarity switching impractical. Thus, I reasoned be compensated by online
calibration of FT spectra using the so called ’lock mass option’ 1 (42). In that way,
FT spectra could have been acquired immediately after the polarity switch. Abundant
peaks of chemical background could provide the lock masses. These compounds vary
with the composition of the analyzed samples, solvents, plasticware and instrument
settings.
In order to specify the chemical background, I ﬁrst established a routine that iden-
tiﬁed optimal reference peaks in any collection of spectra in a project speciﬁc manner.
I randomly selected ﬁve acquired FT MS spectra that were acquired at R m/z 400 of
130.000 (FWHM) on LTQ Orbitrap from diﬀerent total lipid extracts in positive and
negative mode under stable instrument calibration. FT MS spectra from blank an-
alytes, acquired at the same resolution, which were processed as the other samples
but contained no lipids, were added to this data set. All spectra were imported by
the LipidXplorer software into the MasterScan. Individual scans were merged for each
analyzed sample and then related peaks were aligned according to m/z dependent
resolution (36). While data processing, the LipidXplorer software applied several user-
deﬁned thresholds on mass tolerance, intensities and occupancy of the aligned peaks.
The latter determines the frequency with which each reported peak had to be observed
in the spectra of individual samples within the entire series of experiments. At an occu-
pancy threshold of 1.0 (or 100 %), the LipidXplorer software only recognized peaks that
were present in all samples and the controls, i.e. ubiquitous background peaks, whose
masses were not aﬀected by possible overlap with other peaks. They were attributed
to common detergents and plasticizes by accurate determined m/z and subsequently
acquired MSn data (Table 3.1 and Figure A-1) (43). At m/z below 400 I could deter-
mine peaks of docosenoamide cation ([M + H]+ in FT MS(+), calc. m/z 338.341740)
and anions of palmitic ([M − H]−, calc. m/z 255.232954) and stearic acid ([M − H]−,
calc. m/z 283.264254) (not included in Table 3.1). Polydimethylcyclosiloxane cation
([M + H]+, calc. m/z 445.120025)), the common lock mass for reversed phase liquid
chromatography RP-LC-FT MS applications, was not detected in direct infusion ex-
periments. The use of internal lipid standards as lock masses was also precluded since
the signals of lock masses are not reported in the FT MS spectra.
1A speciﬁed number of ions of a characterized compound, originating from the chemical background,
is trapped in the C-trap and injected together with the ions of interest to the Orbitrap.
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Table 3.1: Abundant background ions in FT MS spectra observed in total lipid
extracts. – The identity of precursor ions a-f was conﬁrmed by MSn experiments (Figure
A-1). Homologes of polyethylenglycol g were speciﬁed by their accurate measured m/z.
Name Elemental Precursor ion Calculated Experimental
composition m/z m/z
Octaethylene glycol a C16H34O9 [M + NH4]
+ 388.254107 388.2543
Nonaethylene glycol b C18H38O10 [M + NH4]
+ 432.280322 432.2805
Decaethylene glycol g C20H42O11 [M + NH4]
+ 476.306536 476.3065
Octadecyl (di-tert-butyl- C35H62O3 [M − H]− 529.462621 529.4629
hydroxyphenyl)propionate c
Tris(di-tert-butylphenyl) phosphite d C42H63O3P [M + H]
+ 647.458757 647.4591
Tris(di-tert-butylphenyl) phosphate e C42H63O4P [M + H]
+ 663.453672 663.4583
[M + NH4]
+ 680.480221 680.4805
Pentaerythritol tetrakis- C73H108O12 [M + NH4]
+ 1194.817903 1194.8180
((di-tert-butyl-hydroxy- [M − H]− 1175.776804 1175.7766
phenyl)propionate) f
The analysis of FT MS data from diﬀerent extracts by the LipidXplorer software
indicated a set of experiment speciﬁc background compounds. Subsequent MSn mea-
surements enabled their identiﬁcation and the calculation of the exact monoisotopic
masses that are required for the lock mass option.
3.1.3 Lock mass option preserves mass accuracy upon successive po-
larity switching
FT MS spectra of a commercial bovine heart extract were measured via direct infusion
under diﬀerent instrumental conditions to examine the use of FT MS online calibration
by lock mass option. Therefore, ﬁve FT MS(+) spectra of a polar bovine heart extract
and one blank were acquired prior to polarity switching, under conditions of stable
instrument electronics, to obtain a reference dataset. Then, FT MS(+) and FT MS(−)
spectra from aliquots of the same lipid extract were successively acquired 5 times with-
out using the lock mass option to monitor the eﬀect of the polarity switch onto the
instrument performance. M/z and intensity of abundant lipid PC-O 34:3 ([M + H]+,
calc. m/z 742.574516 in positive and [M + HCOO]−, calc. m/z 786.565443 in negative
modes) were extracted from acquired raw data for each FT MS scan. The relative dif-
ferences between measured and calculated m/z were plotted over the acquisition time
(Figure 3.3). Upon switching of the polarity, the peak m/z was systematically shifted
and it took more then 60 min to settle the mass accuracy back to ppm level as speciﬁed
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for the instrument.
FT MS(+) and FT MS(−) spectra were again acquired from the lipid extract, but
now with the lock mass option enabled. Tris(di-tert-butylphenyl)phosphite and phos-
phate (calc. m/z 647.458757, m/z 663.453672 and m/z 680.480221) and octadecyl(di-
tert-butylhydroxyphenyl) propionate (calc. m/z 529.462621) were used as lock masses
for positive and negative acquisition modes, respectively (Table 3.1). We observed that
the lock mass option or online calibration fully compensated mass shifts in both modes
starting from the acquisition onset (Figure 3.3).
0 500 1000 1500 2000 2500
-4
-3
-2
-1
0
1
2
3
4
5
6
7  without lockmass
 with lockmass
M
as
s a
cc
ur
ac
y,
 p
pm
Acquisition time, s
0 500 1000 1500 2000 2500
-4
-3
-2
-1
0
1
2
3
4
5
6
7  without lockmass
 with lockmass
M
as
s a
cc
ur
ac
y,
 p
pm
Acquisition time, s
A B
Figure 3.3: Engaging of the lock mass option maintained sub-ppm mass ac-
curacy under successive altered acquisition polarity. – LTQ Orbitrap XL was
switched (A) from negative to positive and (B) from positive to negative modes. Upon
polarity switch, the m/z was reproducibly, shifted in time by several ppm if no online cali-
bration was performed. Engaging of the lock mass option reduced the mass shift to −0.21
± 0.23 ppm for FT MS(+) and 0.55 ± 0.15 ppm for FT MS(−), respectively. Relative
mass diﬀerences are reported for the precursor ion of PC-O 34:3 ([M + H]+, calc. m/z
742.574516; [M + HCOO]−, calc. m/z 786.565443). In total, the plots encompass 762 and
712 FT MS(+) and FT MS(−) spectra, respectively.
Hence, I demonstrated that online calibration of FT MS spectra based on chemical
background ions helped to maintain the sub-ppm mass accuracy from the acquisition
onset after switching the instrument polarity. This allows reliable assignment of mole-
cular formulas and thus the identiﬁcation of lipids from high resolution FT MS data in
dual-polarity acquisition experiments.
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3.1.4 Improved lipidomics coverage by automated acquisition of FT
MS in both polarities
As a proof-of-principle experiment for automated lipidomics by successive acquisition
of FT MS(+) and FT MS(−) spectra I analyzed a commercially available polar lipid
extract of bovine heart. The acquisition was set up as previously described (Section
3.1.1). The cycle was 10 times repeated. Within the test run, the acquisition of the
ﬁrst and the last FT MS spectra in the same polarity mode were spaced by 66.5 min.
Measured FT MS(+) and FT MS(−) spectra were interpreted by the LipidXplorer
software (Table 3.2).
Table 3.2: Number of lipid species identiﬁed in a polar bovine heart extract
by successive acquisition of FT MS(−) and FT MS(+). – Lipid species detected
by FT MS showed a mass error in the sub-ppm range; −0.09 ± 0.52 ppm in FT MS(+)
and −0.53 ± 0.81 ppm in FT MS(−).
Lipid Species identiﬁed in: Total, per
class FT MS(+) FT MS(+) and FT MS(−) lipid class
only FT MS(−) only
CholE 2 — — 2
TAG 41 37 — 78
DAG — 6 21 27
MAG — — 3 3
Cer — — 8 8
SM — 17 3 20
PE 1 16 11 28
PE-O 1 18 17 36
LPE — 4 6 10
PC — 17 20 37
PC-O — 17 14 31
LPC — 6 5 11
PS — 1 1 2
PI — 8 10 18
LPI — — 1 1
CL — — 5 5
mLCL — — 3 3
dLCL — — 1 1
PG — — 10 10
Total, per
polarity 45 147 139 331
mode
By matching of the accurate measured masses and the theoretical masses, that
are deﬁned by compositional constrains equal to molecular formulas, the LipidXplorer
software identiﬁed 192 and 286 lipid precursors in FT MS(+) and FT MS(−) data,
27
3. RESULTS AND DISCUSSION
respectively. CholE were only detectable in positive mode; CL, mLCL, dLCL, PG,
LPI, MAG and Cer (see Glossary for abbreviations) were only identiﬁed in negative
mode, while 147 precursors of PC, PC-O, LPC, PE, PE-O, LPE, PS, PI, SM, DAG
and TAG (ibid.) were detected in both modes. In total 331 lipid precursors could
be identiﬁed by FT MS analysis in both acquisition modes. This increased the total
number of detected species by approx. 72 %, compared to the analysis in positive mode
only. Compared to negative mode only, the number of identiﬁed lipid species increased
by 16 %.
Next, I checked if engaging the lock mass or instability of the instrument electronics
aﬀected the detector response and thus the quantiﬁcation of lipid species. To this end
I correlated the relative abundance of 37 unique lipid precursors of PE, PE-O and
LPE that were identiﬁed both in FT MS(+) and FT MS(−) spectra of bovine heart
extract (Table 3.3). The correlation coeﬃcient was found to be 0.9997 comparing
FT MS(+) without and with engaged lock mass when the instrument remained under
stable condition. A similar result was obtained when the polarity was switched from
negative to positive mode: R2 of 0.9998. Obtained FT MS(−) data also showed a
good correlation R2 of 0.9799. From this data I concluded that engaged lock mass and
switching of the polarity does not eﬀect the proﬁle of detected species and consequently
the lipid quantiﬁcation.
Table 3.3: Correlation of the relative abundances of PE, PE-O and LPE species
identiﬁed in FT MS spectra of a polar lipid extract from bovine heart. –
The relative abundances were calculated by normalization of precursor signal to their
sum intensity. Correlation coeﬃcients were calculated relative to FT MS(+) data obtain
under stable instrument conditions and with no lock mass engaged. Lock masses used
for FT MS(+) were m/z 647.458757, 663.453672 and 680.480221; for FT MS(−) was m/z
529.462621.
Acquisition mode Polarity switch Lock mass R2 Slope
FT MS(+) no no n.d. n.d.
FT MS(+) no yes 0.9997 0.9914
FT MS(+) yes yes 0.9998 0.9727
FT MS(−) yes yes 0.9799 1.0157
I therefore concluded that lipidomics analysis with successive switching of the ac-
quisition polarity allows to utilize the complete information that can be obtained from
one sample of a speciﬁc composition. The coverage of lipid classes and species was
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increased compared to acquisitions in a single polarity mode. Thus, when analyzing a
series of samples, switching the polarity for each individual sample saved lipid material
and decreased the total analysis time, while lipid identiﬁcation and quantiﬁcation were
not negatively aﬀected.
3.1.5 Application of dual-polarity acquisitions in clinical lipidomics
screens
I then used this approach to analyze total lipid extracts of human blood plasma, which
is similar to the previously published methodology (17, 18). However, this time FT
MS spectra were acquired in both acquisition modes from the identical sample (Figure
3.4).
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Figure 3.4: Lipidomics of human blood plasma lipid extracts by successively
measured FT MS(−) and FT MS(+). – (A) Total ion current (TIC) recorded over
the full analysis time. The value increased when the polarity was switched to positive after
3.5 min. (B) Averaged FT MS(−) spectra acquired between 1.5 to 3.5 min. (C) Averaged
FT MS(+) spectra acquired between 5.0 to 7.0 min in positive mode. In both spectra the
most abundant peaks were annotated with lipid identiﬁcation, m/z and its relative mass
diﬀerence to calculated m/z (in ppm).
29
3. RESULTS AND DISCUSSION
In the test series with ten individual plasma samples, LipidXplorer identiﬁed 222
lipid species from 15 classes in the measured FT MS(+) and FT MS(−) data set based
on their accurate measured m/z. From this, 62 lipids were detected only in positive
(including 44 TAG species) and 68 lipids only in negative modes (Table 3.4).
Table 3.4: Number of lipid species identiﬁed in a total extracts of human blood
plasma by successive acquisition of FT MS(−) and FT MS(+). – Lipid species
detected by FT MS showed a mass error in the sub-ppm range; −0.01 ± 0.51 ppm in FT
MS(+) and 0.42 ± 0.57 ppm in FT MS(−). The full list of lipid species and their average
concentrations in human blood plasma is reported in Table A-2.
Lipid Species identiﬁed in: Total, per
class FT MS(+) FT MS(+) and FT MS(−) lipid class
only FT MS(−) only
Chol 1 — — 1
CholE 17 — — 17
TAG 44 6 — 50
DAG — 6 7 13
Cer — 2 6 8
SM — 27 — 27
PE — — 11 11
PE-O — 3 13 16
LPE — — 7 7
PC — 18 13 31
PC-O — 14 — 14
LPC — 9 4 13
LPC-O — 3 — 3
PS — — 3 3
PI — 4 4 8
Total, per
polarity 62 92 68 222
mode
Dual-polarity acquisition of lipids has two important implications. First, we de-
tected 44 % more species compared to conventional positive mode-only analyses. Fur-
thermore, the analysis encompassed ﬁve more lipid classes: DAG, Cer, LPC-O, PS and
PI, compared to the previously reported positive mode only top-down shotgun screen
(18). Second, major GPL species of PE (PE 36:1, PE 36:2, PE 38:3) and LPE (LPE
18:0) were accurately quantiﬁed because, in negative mode, they were unequivocally
distinguished from isobaric endogenous PC with odd numbered FA moieties (e.g. PC
33:1, PC 35:2, PC 35:3 and LPC 15:0). The total content of major classes of GPL
and SM, calculated from the abundances of individual species, agreed well with the
previously reported values (44). Within each lipid class, the relative abundance of in-
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dividual species generally followed the published proﬁles although in many instances
substantial deviations occurred (10). This, however, would be expected considering
remarkable compositional diversity conﬁrmed in numerous clinical screens (18, 45, 46).
To validate potentially ambiguous assignments, I further acquired HCD FT MS/MS
spectra from precursor ions of the lipid classes that (I) were only detectable in one po-
larity mode and (II) may overlap with another major lipid class because of the identical
composition of heteroatoms (31). In this way, I was able to distinguish molecular an-
ions of PS ([M − H]−) from formate adducts of PC ([M + HCOO]−) that comprise
odd numbered FA moieties and have identical exact masses (Figure 3.5).
Figure 3.5 (facing page): HCD FT MS/MS conﬁrms the presence of PC species
with odd numbered FAs in human blood plasma. – (A) FT MS(−) of a blood
plasma total lipid extract; zoomed region shows the precursors of PE 40:6, PC-O 34:1 and
PC 33:1 ([M + HCOO]−) or PS 36:0 ([M − H]−). The latter have the same m/z. (B)
HCD FT MS/MS(−) of this precursors. The products of demethylation (neutral loss (NL)
of C2H4O2; Δ m/z of −60.0211 Th) are speciﬁc to species with choline head group. The
corresponding zoom is shown below.
Considering the detected fragments of carboxylate ions and losses of FA ketens, possible
species are: PC 15:0/18:1 ([M1 – CH3 – FA 18:1]
− at m/z 466.2943 (0.79 ppm); [FA 18:1
− H]− at m/z 281.2491 (1.69 ppm); [FA 15:0 − H]− at m/z 241.2176 (1.23 ppm)); PC
16:0/17:1 ([M1 – CH3 – FA 16:0]
− at m/z 492.3100 (0.91 ppm); [FA 17:1 − H]− at m/z
267.2334 (1.67 ppm); [FA 16:0 − H]− at m/z 255.2334 (1.59 ppm)); PC 16:1/17:0 ([M1
– CH3 – FA 16:1]
− at m/z 494.3256 (0.80 ppm); [FA 16:1 − H]− at m/z 253.2176 (1.33
ppm); [FA 17:0 − H]− at m/z 269.2490 (1.29 ppm)). PC-O 16:0/18:1 ([M2 – CH3 – FA
18:1]− at m/z 466.3307 (0.93 ppm); [FA 18:1 − H]− at m/z 281.2491 (1.69 ppm)); PC-O
18:0/16:1 ([M2 – CH3 – FA 16:1]
− at m/z 494.3622 (1.32 ppm); [FA 16:1 − H]− at m/z
253.2176 (1.33 ppm)); PC-O 18:1/16:0 ([M2 – CH3 – FA 18:1]
− at m/z 492.3465 (1.04
ppm); [FA 16:0 − H]− at m/z 255.2334 (1.59 ppm)).
At the same time, fragments speciﬁc for PS 36:0: the expected NL of C3H5O2N (Δ m/z
of −87.0320 Th; zoomed at the inset) and [M1 – C3H5O2N – FA 18:0] were undetectable
with a mass tolerance less than 10 ppm. I concluded thereof that PS 36:0 was not present
in these plasma samples.
FT MS(−) and HCD FT MS/MS(−) spectra were acquired in the proﬁle mode under
operator control on LTQ Orbitrap Velos instrument as previously described (47). Diﬀer-
ently, both were acquired at the target mass resolution of R m/z 400 of 130.000 (FWHM).
Maximum injection time for HCD FT MS/MS was set to 8 s.
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3.1 Top-down lipidomics on LTQ Orbitrap mass spectrometers by
successive switching of the acquisition polarity
3.1.6 Discussion
With this experiments, I demonstrated that successive switching of the acquisition
polarity can be performed on high resolution LTQ Orbitrap mass spectrometers which
maximizes the information content of top-down lipidomics screens. Both, positive and
negative FT MS (and, if required, many MS/MS) spectra could be acquired in rapid
succession within the same non-interrupted sequence. Mass accuracy during dual-
polarity experiments was ensured by online calibration of the FT MS spectra using
lock masses. These masses were identiﬁed from the chemical background and are known
plastic modiﬁers (43).
The established method reduces material costs and working time. In absolute terms:
the lipidomics analysis of 192 plasma samples would, according to the previous meth-
ods, require (I) 4 h for manual plating of the samples; (II) 1.34 h for stabilization of the
instrument; (III) 5.34 h for sample delivery by the NanoMate robot, which prolongates
the dead time in the lipidomics experiment, and (IV) 2 nESI chips and a corresponding
number of sample tips of about 1600 e. In the described method (I) online calibration
by lock masses ensured mass accuracy and (II) sample delivery time and amount, work-
ing time plus material costs were halved, whereas neither throughput nor sensitivity
were compromised. Time and materials can be used instead to perform more speciﬁc
measurements, e.g. with changed pH of the spraying solution to enhance the ionization
of ceramides (17).
Altogether, the use of the method for clinical application was demonstrated by dual-
polarity acquisition of lipids in human blood plasma. The analysis covered 222 lipid
species from the 15 major lipid classes, while the total analysis time was 7 minutes per
sample and could be further reduced as low as 5 min.
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3.2 Bottom-up shotgun lipidomics by higher energy col-
lisional dissociation on Orbitrap mass spectrometers
Detailed information of the molecular composition of the lipidome can be achieved
by species speciﬁc fragments generated upon dissociation of the intact lipid precursors.
The following experiments aim to establish the bottom-up shotgun lipidomics approach
on LTQ Orbitrap instruments whereas particular focus was put on the recently imple-
mented higher energy collisional dissociation (HCD) fragmentation.
3.2.1 Isolation of lipid precursor ions by the LTQ
If lipid species of the same class diﬀer by a double bond in their hydrocarbon moieties,
their precursors are spaced by a Δ m/z of 2.0157 Th. Since in MS/MS experiments
these precursors may produce the same fragment (like, the precursor ion of PC species),
it would be advantageous for identiﬁcation and quantiﬁcation to fragment their peaks
separately, and therefore in DDA of MS/MS and MPIS or FAS isolation is performed
at unit or higher mass resolution (32, 34).
The aim of this experiment was to characterize the precursor isolation performed by
commercial linear traps named LTQ and LTQ Velos. First of all, I tested the accuracy
of the ion isolation. The isolation width was therefore set to 1.0 Th. Normalized
collision energy (nCE, (48)) was maintained at 1 % such that precursors remained
intact. CID IT and FT MS/MS spectra were acquired for PC 16:0/22:6 in positive (as
[M + H]+) and negative (as [M + HCOO]−) acquisition modes on the LTQ Orbitrap
XL and Velos, following abbreviated as XL and Velos, while changing the target mass
from theoretical m/z −1.0 Th to theoretical m/z +1.0 Th in 0.1 Th steps (Figure 3.6).
Note that in these experiments no internal standards could be employed to compensate
for spraying instability.
According to this observation the maximum intensity of a monoisotopic precursor
ion could be obtained only by application of a mass oﬀset 1 on both the XL and Velos.
The unequal oﬀset applied at XL and Velos machines results from the diﬀerences in
design of ion traps and ion isolation procedures.
1The mass oﬀset is the diﬀerence between the precursor m/z and the m/z targeted for a MS/MS
experiment
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Figure 3.6: Oﬀset precursor isolation on LTQ Orbitrap instruments. – The
relative intensity of the monoisotopic precursor ion of PC 16:0/22:6 isolated by the linear
ion traps at the XL and Velos in (A) positive mode ([M + H]+; calc. m/z 806.5694) and
(B) negative mode ([M + HCOO]−; calc. m/z 850.5593). In positive mode, the average
precursorm/z measured in MS experiments were 806.42 (−0.15 Th) on IT; 806.5684 (−1.24
ppm) in FT MS at the XL; and +806.65 (+0.08 Th) on FT MS at the Velos. In negative
mode, the average precursor m/z measured in MS experiments were 850.32 (−0.24 Th) on
IT; 806.5603 (−0.10 ppm) on FT MS at the XL; and 850.5609 (+0.62 ppm) on IT at the
Velos. At the x-axis, the mass oﬀset was calculated as the diﬀerence between the target
and calculated precursor m/z ; y-axis, the precursor ion abundance was normalized to the
maximum value observed in each experiment. IT/IT is used in place of CID IT MS/MS
in which the precursor ion was isolated and detected at the ion trap; IT/FT, in place of
CID FT MS/MS where the precursor ion was isolated at the ion trap and detected at the
Orbitrap.
Further isolation experiments with diﬀerent standards suggested that at both XL
and Velos, the mass oﬀset did not change if automatic gain control (AGC) 1 was set
to a higher target value (e.g. 30.000 instead of 5.000 ions). At the same instrument,
the oﬀset did not change between positive and negative modes and showed day-to-day
variation within the range of 0.1 Th (Figure 3.6). For the same polarity, the oﬀset was
unaﬀected by changing the isolation width within 1.0 to 1.8 Th, although the abundance
of isolated peaks changed considerably (Figure 3.7). Increase of the isolation width to
1.8 Th was allowed since no interfering isotopic peaks were co-isolated.
1The AGC prevents the overﬁlling of ion trap devices. It is performed (I) by pre-measure of the ion
current for a particular m/z and (II) by subsequent adjustment of the ion accumulation or injection
time (49).
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Figure 3.7: Enhanced ion transmission by extension of the isolation width. –
Relative intensity of the precursor ion of (A) PC 16:0/22:6 ([M + HCOO]−) and (B) PE
16:0/22:6 ([M − H]−) after isolation by LTQ at XL. The isolation width was stepwise
increased from 1.0 Th to 2.0 Th. Maximum injection time was 100 ms, AGC was set to
5.000 (ions) and nCE to 1 %. On LTQ Orbitrap XL more than 10 % of PC 16:0/22:6
([M + HCOO]−) precursor ion are recovered at 1 Th isolation width when performing the
MS/MS. The transmission increased at an isolation width of 1.5 Th to approximately 38
% and 84 % at 1.8 Th, respectively.
Another concerned was that the oﬀsets would be substance dependent since isolation
under the unit resolution on LTQs might degrade unstable precursors like Cer (50, 51).
Therefore, I acquired additional total ion map data 1 from the precursors of 11 synthetic
lipid standards and determined their mass oﬀsets and their variations. With an isolation
width of 1.5 Th, the optimal mass oﬀset was, on average, 0.4 Th on the XL and
independent of the lipid class or m/z of the species.
I therefore concluded that applying of mass oﬀsets is important for the unit isolation
of lipid precursors on LTQ instruments. The actual mass oﬀset depend on the IT
design but were weakly aﬀected by acquisition polarity, AGC target values, width of
the isolation window, as well as m/z and structure of the isolated lipid precursor. Once
determined in experiments with referent substances, the same mass oﬀset was applied
for DDA of MS/MS of multiple lipid classes.
Second, I analyzed the transmission of molecular ions for diﬀerent lipid analytes
depending on the isolation width because they might be aﬀected by IT excitation (51).
Therefore I ﬁxed the mass oﬀset, the nCE to 1 % and determined how the abundance
1The ”ion map”, or ion intensity map is a two-dimensional plot of fragment spectra over precursor
m/z.
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of monoisotopic peaks was aﬀected by the isolation width. For comparative testing I
used PC 16:0/22:6 detected as [M + CH3COO]
− and PE 18:0/22:6 detected as [M −
H]− in the negative ion mode (Figure 3.7).
The monoisotopic peak of the molecular anion of PE could be isolated with no major
losses down to an isolation width of 1.0 Th. Under the same settings the monoisotopic
peak of the acetate adduct of PC was undetectable, while its intensity was enhanced
with increasing the isolation width. The MS/MS spectra contained no [M − CH3]−
fragment ions of demethylated PC (52). I reasoned that at an isolation width of 1.0 Th
isolation degraded the [M + CH3COO]
− adduct, while its major collisional dissociation
product [M − CH3]− was not trapped. Although I could detect the peak of acetate
adduct at the Velos even at the 1.0 Th isolation window, its abundance was 2.5 times
lower compared to the isolation at the ’fully opened’ window of 2.0 Th. Further it
is important to mention that the ﬁrst isotope of both species was not detected at an
isolation width of 2.0 Th.
Furthermore, I could observe that molecular ions of several lipid classes, such as
sphingolipids, steroids and their esters, suﬀered from isolation in the LTQs. It was
almost impossible to isolate their precursors with an isolation width of less than 3.0 Th
due to their instability, which was a clear limitation for bottom-up shotgun lipidomics
experiments on this instruments. This issue could be circumvented by targeting dif-
ferent molecular ion forms. Thus, it is possible to analyze Cer on LTQ instruments in
their deprotonated form ([M − H]−).
3.2.2 Comparison of CID, PQD and HCD
Once precursor ions have been isolated by the LTQ, both the XL and Velos oﬀer
multiple ways for their subsequent MS/MS analysis. They can be fragmented in the
linear ion trap by ion trap CID or PQD or by HCD in the separate multipole collision
cell attached to the C-trap. The aim of the following experiments was to examine the
analytical merits of diﬀerent fragmentation means for identifying molecular species of
common GPLs classes.
Molecular species of GPLs are usually identiﬁed by their precursor mass and the
corresponding FA moieties. Using the standard of PE 18:0/18:1, I compared the eﬃ-
ciency of precursor ion fragmentation and the yield of carboxylate ions in CID, PQD,
and HCD modes (Figure 3.8).
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Figure 3.8: Normalized collision energy proﬁles of PE 18:0/18:1 generated by
CID, PQD, and HCD FT MS/MS on the Velos. – Precursor ion of PE 18:0/18:1
([M − H]−, m/z 744.5549) was isolated in the LTQ and fragmented by CID (A), PQD (B),
and HCD (C). Fragments were detected by the Orbitrap analyzer. M/z of fragment ions:
[FA 18:0 − H]− at m/z 283.2643; [FA 18:1 − H]− at m/z 281.2486. NLs substitutes the
combined intensity of m/z 480.3091 and m/z 478.2933, the NL products of ketens of 18:1
and 18:0 FAs, respectively.
Although the precursor ion could be completely fragmented by all three methods,
there are two reasons why HCD oﬀers better recovery of carboxylate ions: (I) HCD is
a multiple collision process. Similar to the fragmentation in classical QqQ instruments,
multiple collisions of both precursors and intermediates cause their degradation to the
more stable fragments, which are in this case the carboxylate ions of FA 18:0 and
FA 18:1. (II) The HCD cell C-trap Orbitrap scheme is more permissive toward the
transmission and detection of low molecular weight fragments, compared to LTQ it is
only limited by rf amplitude of the C-trap and cuts oﬀ m/z below (approximately) 1/20
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of the precursor m/z and therefore does not compromise the detection of carboxylate
ions. In comparison, the LTQ has a cut oﬀ m/z at 1/4 of the precursor m/z by default.
This value can be reduced but involves a reduction of the trapping eﬃciency.
Furthermore, I observed that in HCD mode, normalizing the collision energy (CE)
1 enabled equally eﬃcient fragmentation of the same class species, irrespective of their
m/z. The observed recoveries of carboxylate ions were similar for saturated species
of the same lipid class at diﬀerent nCEs (Figure 3.9). Similar breakdown curves were
obtained on hybrid quadrupole TOF mass spectrometers (32, 53). HCD of PI required
slightly higher nCE compared to PC and PE, while maximum recovery of saturated
carboxylate ions of all classes was achieved at nCE of 65 % on XL and Velos.
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Figure 3.9: Normalization of the collision energy ensured m/z independent
fragmentation. – 5 synthetic PC standards (PC 12:0/12:0, PC 14:0/14:0, PC 18:0/18:0,
PC 22:0/22:0 and PC 24:0/24:0) were diluted to the concentration of 0.1  M and analyzed
by direct infusion into the LTQ Orbitrap Velos at R m/z 400 of 10.000. HCD FT MS/MS(−)
spectra of corresponding formate adducts [M + HCOO]− were acquired with stepwise
increased nCE (from 0 to 125 %). The carboxylate ion intensity is depicted as function of
CE (A) and nCE (B). Each data point represents the average and SD of 3 experiments.
I then estimated the dynamic range of quantiﬁcation by HCD FT MS/MS for
diﬀerent lipid classes. Test samples were obtained by a serial dilution of a mixture of
seven synthetic lipid standards. Precursor masses were subjected to HCD FT MS/MS,
and the combined intensity of peaks of carboxylate ions plotted against the species
concentrations. A linear response over four orders of dynamic concentration range for
each of the quantiﬁed standards was obtained (Figure 3.10).
1nCEHCD[%] = (CE[eV] * 1000) / (m/z * z)
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I therefore concluded that, on instruments of the Orbitrap family, HCD outper-
formed CID and PQD in quantitative molecular species proﬁling, whereas the intensity
of speciﬁc ions could be enhanced by an adjustment of the collision energy. Normal-
ization of the CE enabled one to achieve an equally complete yield of carboxylate ions
from saturated GPL precursors independent of their m/z, molecular forms (molecular
anions or anion adducts), and class.
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Figure 3.10: Dynamic range of lipid quantiﬁcation using HCD FT MS/MS(−)
on the LTQ Orbitrap Velos. – The calibration plots were obtained by analyzing serial
dilution samples of a mixture of synthetic lipid standards: PC 17:0 / 17:0, PE 17:0/17:0, PI
16:0/16:0, PS 12:0/12:0, PG 17:0/17:0 and CL 14:0/14:0/14:0/14:0 within a concentration
range of to 0.1 nM to 10  M, while SM d18:1/17:0 in the concentration of 0.5  M was used
as an internal standard. Quantiﬁcation was based on the combined intensity of carboxylate
ions. AGC target was set to 5 × 104, isolation width to 1.5 Th, oﬀset to 0.0 Da, nCE to
70 %.
3.2.3 Correct assignment of fragments by high resolution MS/MS
Quantitative proﬁling of GPL species via anions of their FA moieties is an established
analytical approach used on hybrid quadrupole TOF mass spectrometers in multiple
precursor ion scanning (MPIS) (17, 32) and data dependent acquisition (DDA) (34)
modes. Results obtained in independent DDA and MPIS experiments corroborate,
and the linear dynamic range of species detection exceeds four orders of magnitude
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(17, 32, 34). Here I examined whether DDA of HCD FT MS/MS of GPL anions could
be applied for molecular species proﬁling in the same way.
Together with high mass resolution and ppm mass accuracy of the Orbitrap mass
analyzer, HCD enabled unequivocal assignment of fragment ions in MS/MS spectra and
was particularly important for the quantiﬁcation of lipids with polyunsaturated fatty
acids (PUFA) moieties. In MS/MS, carboxylate ions of PUFA species produce speciﬁc
neutral losses of CO2 (32, 54). In this way, anion of docosahexaenoic acid ([FA 22:6 −
H]−) produces a fragment with calculated m/z 283.2431, which is isobaric to the anion
of abundant stearic acid ([FA 18:0 − H]−, m/z 283.2643). While their peaks overlap in
low resolution MS/MS spectra, they were completely resolved in FT MS/MS spectra
with R above 30.000 (Figure 3.11). Therefore, intensities can be accurately assigned to
carboxylate ions and their fragments. No correction of the intensity of carboxylate ion
[FA 18:0 − H]− is required afterwards (32).
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Figure 3.11: High resolution HCD FT MS/MS of PE 18:0/22:6. – HCD FT
MS/MS of PE 18:0/22:6 ([M − H]−) acquired at R m/z 400 of 40.000. Peaks of carboxylate
ion [FA 18:0 − H]− (m/z 283.2636) and the NL of CO2 (m/z 283.2425) from carboxylate
ion [FA 22:6 − H]− (m/z 327.2323) were resolved.
An increase of the targeted resolution R m/z 400 to 130.000 in MS/MS has been
found to be useful as well. (I) This enables the discrimination of PCs with odd from
PC-Os with even numbered FA moieties (Δ m/z of 0.036 Th) by lipid class speciﬁc
neutral loss of methyl formate (Figure 3.5). (II) Monoisotopic and isotopic signals of
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carboxylate ions with Δ m/z of 0.008 Th become resolved as the second isotope of
carboxylate ion [FA 18:2 − H]− (m/z 281.2405) and the monoisotope of carboxylate
ion [FA 18:1 − H]− (m/z 281.2483) (Figure 1.7).
3.2.4 Application of high resolution FT MS and HCD FT MS/MS to
explore the glycerophospholipidome of the retina
I validated the setup DDA HCD FT MS/MS method by analyzing the glycerophospho-
lipidome of a rat retina, which was supposed to contain high amounts of unsaturated
lipid species (55). For the lipid analysis, I extracted 7 mg of retina tissue using the
MTBE recipe (56). Each shotgun analysis consumed 820 pmol of the total lipid mate-
rial and produced a data set of 125 FT MS and 600 HCD FT MS/MS spectra acquired
using the inclusion list of precursor m/z computed from expected chemical formulas of
GPL species. In order to trigger an HCD FT MS/MS, the m/z in the inclusion list had
to ﬁt to a corresponding FT MS signal by ± 10 ppm. The isolation width was set to 1.5
Th, so that isobaric precursors were fragmented together, while individual species were
recognized and quantiﬁed in ’mixed’ MS/MS spectra by lipid class speciﬁc and lipids
species speciﬁc fragment ions. The analysis for the total extract was 4 times repeated.
Molecular species were identiﬁed by the LipidXplorer software (Figure 3.12).
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Figure 3.12: Major molecular species of glycerophospholipids in rat retina.
– For presentation clarity, only 50 species which abundances exceeded 75 pmol/mg are
shown. The full list comprising 211 molecular species is provided in the Table A-4.
42
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on Orbitrap mass spectrometers
The bulk lipid class composition independently determined by FT MS and HCD FT
MS/MS in positive and negative modes corroborated previous publications on mam-
malian retinas (57, 58). Other lipid classes, such as SLs or GLs, were not studied here.
Also, I did not distinguish plasmanyl- from plasmenyl GPLs in the data analysis.
The ability to analyze a broad m/z range from 100 to 2000 by the Orbitrap analyzer
without extension of the measurement time enabled the identiﬁcation of interesting
precursor ions for DDA of MS/MS apart from common lipid species (34, 59). Hence,
I was able to detect GPL species with VLC PUFA. As a representative example, the
HCD FT MS/MS spectrum of the major PC with VLC PUFA the PC 32:6/22:6 ([M +
HCOO]−, m/z 1062.7171) is presented in Figure 3.13. Conﬁdence for the identiﬁcation
of this VLC PUFA species was achieved based on multiple fragments matching with
sub-ppm mass accuracy.
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Figure 3.13: HCD FT MS/MS(−) of a very long chain polyunsaturated PC
32:6/22:6. – As judged by relative intensity of carboxylate ion fragments, VLC PUFA
FA 32:6 was at sn-1 position, while FA 22:6 was at the sn-2 position of the glycerol
backbone. [M − CH3]− was detected at m/z 1002.6955 (−0.24 ppm), the of FA 22:6 as
keten ([C39H67O7NP]
–
, m/z 692.4660, 0.06 ppm), [FA 32:6 − H]− (m/z 467.3893, −0.37
ppm), [FA 22:6 − H]− (m/z 327.2328, −0.53 ppm) and NL product of CO2 from the anion
of FA 22:6 ([FA 22:6 − H − CO2]−, m/z 283.2431, −0.19 ppm). R m/z 400 was set to
40.000 (FWHM); nCE to 45 %.
Since exact quantities of individual species in rat retina were unknown, I seeked
indirect means for validating our quantitative assignments. The lipid quantiﬁcation
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method relying upon HCD FT MS/MS is conceptually similar to the shotgun method-
ology established on a quadrupole TOF mass spectrometer (34, 59). While adapting it
to another instrument, I checked whether the combined abundances of carboxylate ions
and their NL products in MS/MS spectra independently corroborated the abundances
of intact precursors in MS spectra for each lipid class. Indeed, I found that the average
correlation coeﬃcient R2 of FT MS and FT MS/MS data for the molecular species of
the four major classes (PC, PE, PI, and PS) was about 0.992 (Figure 3.14).
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Figure 3.14: Correlation between relative abundances of molecular lipid species
in FT MS(−) and HCD FT MS/MS(−) spectra. – The intensities of precursor ions
were obtained from FT MS(−) spectra. In HCD FT MS/MS(−) spectra the intensities of
corresponding carboxylate ions and CO2 loss products were summed up. Each data point
represents the average relative intensity and SD. Correlation coeﬃcients R2 were calculated
separately for each lipid class.
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on Orbitrap mass spectrometers
High resolution HCD FT MS/MS allowed the correct assignment of carboxylate
ions and their speciﬁc fragments. However, this did not imply that accounting for
CO2 losses from PUFA carboxylate ions enables setting nCE at some high arbitrary
values. At nCE > 50 % I observed substantial uncompensated losses especially in the
abundances of carboxylate ion [FA 22:6 − H]−, in contrast to carboxylate ions having
0 to 2 double bonds. As a compromise for accurate accounting of the PUFA containing
species, nCE was reduced. Incomplete fragmentation of lipid species reduced thereby
the detection sensitivity in particular of PIs.
3.2.5 Discussion
The performed experiments showed that HCD fragmentation together with FT MS
detection is a powerful tool for quantitative proﬁling of molecular lipid species. High
mass resolution and mass accuracy of structurally speciﬁc carboxylate ions were the two
important factors that increased both the conﬁdence in molecular species assignment
and quantiﬁcation accuracy. The LipidXplorer software supported the analysis of FT
MS data and allowed to quantify VLC PUFA containing GPLs in retina samples.
Preliminary fragmentation experiments on PUFA containing GPL species showed
that their fragmentation behavior requires to be studied with more detail to improve
the precision and accuracy of quantitative bottom-up lipidomics.
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3.3 Instrumental enhancements for shotgun lipidomics
3.3.1 Safe isolation of labile precursor ions on QExactive hybrid type
instruments
During the experiments on LTQ Orbitrap instruments I realized that precursor isola-
tion of labile lipid analytes such as steroid esters ([M + NH4]
+) and Cer ([M + H]+)
was impossible. Recent improvements of Orbitrap mass spectrometers led to a new
instrument, the QExactive, which uses a standard quadrupole instead of a LTQ for
mass selection. The precursor isolation characteristics of labile molecular ions on the
QExactive instrument were examined with a synthetic standard of Cer d18:1/17:0 ([M
+ H]+).
First, the ion transmission was studied by FT MS SIM msx and the successive
reduction of the isolation width (FWHM) from 10.0 Th to 0.4 Th (Figure 3.15 A).
I observed a decline of the ion transmission by 15 % when the isolation window was
reduced from 10.0 Th to 1.0 Th. At an isolation width of 1.0 Th a signal-to-noise ratio
(S/N) of approximately 2500 was achieved. For comparison, the S/N obtained on the
Velos under the same conditions is 25 times lower.
Although I could detect [M + H − H2O]+ fragment in the MS SIM msx of the Cer
ion its relative intensity did not change with decreasing isolation widths. The trapping
of the precursor ions in the C-trap might causally for this fragmentation. This eﬀect
became clear when the time the ions spend in the C-trap was extended by increase of
the maximum injection time. Then the relative intensity of the water loss increased,
but was always below 10 % in MS SIM msx spectrum.
Second, I tested the accuracy of the precursor isolation. Therefore, the target m/z
was increased from 551.5 to 553.5 in 0.1 Th steps while the isolation width was ﬁxed
to 1.0 Th. The intensity measured in the MS SIM msx spectrum reached its maximum
when the target m/z was equal to the precursor mass (m/z 552.5). Hence, I did not
detect a precursor isolation oﬀset for the isolating quadrupole (Figure 3.15B).
The investigation of the quadrupole performance on the QExactive instrument
demonstrated that now even labile precursor ions can be isolated and subjected to
HCD FT MS/MS analysis. Yet, the analyte of interest has to be stable enough to
withstand the storage in the C-trap to be detectable in FT MS and consequently to
trigger the HCD FT MS/MS in a DDA experiment.
46
3.3 Instrumental enhancements for shotgun lipidomics
A B
551.0 551.5 552.0 552.5 553.0 553.5 554.0
0
20
40
60
80
100
Re
l. 
ab
un
da
nc
e, 
%
Target m/z, Th
1 10
0.0
5.0x106
1.0x107
1.5x107
2.0x107
2.5x107
3.0x107
3.5x107
4.0x107
4.5x107
In
te
ns
ity
Isolation width, Th
Figure 3.15: Isolation of a labile lipid analyte on QExactive. – (A) Transmission of
precursor ions depends on the isolation width of the selecting quadrupole. Singly charged
precursor ion of Cer d18:1/17:0 ([M + H]+; calc. m/z 552.535022) was monitored by FT
MS SIM msx, while the width of isolation window (FWHM) was changing from 10.0 to
0.4 Th (plotted at x-axis in log scale) and the intensity of the precursor peak (plotted at
y-axis) was monitored. (B) Accurate precursor isolation at the QE instrument. The target
mass was scanned with 0.1 Th steps within the range of ± 1.5 Th the calculated m/z of the
precursor which intensity was monitored by FT MS SIM msx. Maximum abundance of the
intact isolated precursor was observed at zero mass oﬀset, i.e when exactly the calculated
precursor m/z was targeted. The plots represents the average and SD of 3 experiments.
3.3.2 Beneﬁts of diﬀerential mobility spectrometry/mass spectrome-
try for shotgun lipidomics
The experiments above showed how high resolution and accurate precursor isolation
allows to specify the quantity of molecular lipid species in total lipid extracts. However,
in some cases the assignment of carboxylate ions to molecular lipid species even by FT
MS/MS was not possible directly. In the case of PC 33:1 and PC-O 34:1 (both [M
+ HCOO]−) the same carboxylate anions are obtained (Figure 3.5). Also, by having
no or only partial separation of lipid classes, the quantiﬁcation of lipid species of e.g.
PE 16:1/16:1 ([M − H]−, calc. m/z 686.47663), which might overlap with CL 16:0-
16:1-16:1-18:1 ([M − 2H]−2, calc. m/z 686.47101)), becomes complicated for both FT
MS (at R below 150.000 (FWHM)) and FT MS/MS. In order to achieve a one-to-one
relation of lipid species and FA moieties, a separation, preferably on the MS level, of
lipid analytes would be desirable.
An interesting opportunity is given by ion mobility and in particular by diﬀeren-
tial mobility, which separates analyte ions in the gas phase upon diﬀerent transport
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properties in high and low electric ﬁelds (60), whereas a signiﬁcant improvement of the
separation can be achieved by addition of modiﬁer solvents to curtain gas (61).
In collaboration with Bradley B. Schneider from ABSciex we performed a set of
DMS/MS and DMS/MS/MS experiments with synthetic lipid standards to evaluate
the separation power and its use for shotgun lipidomics.
3.3.2.1 DMS separation of homologue lipid species
In order to estimate the extend of separation within lipid classes, we analyzed a set
of homologue synthetic PC standards with varying chain length by DMS/MS with
isopropanol as gas phase modiﬁer. The measurements revealed a peak separation for
PC species, that was stronger for species with shorter FA moieties. Correspondingly,
PC 24:0 and PC 28:0 ([M + CH3COO]
−) were measured at compensation voltages
(CV) −0.8 V and 1.6 V. PC 44:0 and PC 48:0 were detected at CV 5.0 V and 5.2 V,
respectively. Summarized, PC species with C30 to C42 acyl carbons were detectable
within a CV range of 2.4 V.
3.3.2.2 Separation of isobaric species by DMS
In this experiment we tested the ability of DMS to separate isobaric lipid species of
diﬀerent lipid classes. Therefore, we analyzed an equimolar mixture (c = 1  M) of
isobaric lipid species PC 16:1/16:1 ([M + CH3COO]
−) and PS 18:0/18:1 ([M − H]−,
calc. m/z 788.544707) by direct infusion DMS/MS. PC 16:1/16:1 was detectable at
a CV −4.5 V; PS 18:0/18:1 at a CV of 7.1 V. Importantly, the intensities were only
slightly eﬀected: 9.5 × 106 cps without DMS; 5.9 × 106 cps for PS 18:0/18:1 plus
2.8 × 106 cps for PC 16:1/16:1 with DMS separation. Thus, DMS allowed the base
separation of both lipid classes in the gas phase on the basis of their distinct transport
properties in the electric ﬁeld. In this way, the intact precursor and FA fragments are
separately detectable by the mass spectrometer.
3.3.2.3 Separation of diacyl- from plasmenyl-PE by DMS
More relevant, with respect to the accurate quantiﬁcation of molecular lipid species
and the one-to-one assignment of fragments, was the question whether diacyl-GPL (as
PC and PE) can be separated from their 2-acyl-1-alkenyl analoga (as PC-O and PE-O)
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by DMS. Therefore, we analyzed an equimolar mixture (c = 1  M) of lipid species PE
18:0/18:0 and PE-O 16:0p/22:6 (both [M − H]−) by direct infusion DMS/MS/MS. We
achieved a separation of both analytes (Figure 3.16). The maxima of their intensity were
detected with a CV diﬀerence of 2.1 V. Consequently, we could measure the MS/MS of
PE 18:0/18:0 separately from PE-O 16:0p/22:6 such that the intensities of carboxylate
ion could be directly assigned even on a low resolution instrument. The overlap of [FA
18:0 − H]− and the CO2 loss of [FA 22:6 − H]− was prevented by separation of the
lipid analytes in the gas phase. Moreover, the separation of both lipid species could
be repeated in positive mode and enabled the detection of NL 141 from PE 18:0/18:0
without bias by the same NL from PE-O 16:0p/22:6 – again at low resolution.
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Figure 3.16: Peak separation of PE and PE-O by DMS. – A equimolar mixture
of PE 18:0/18:0 and PE-O 16:0p/22:6 was measured by direct infusion DMS/MS/MS(−).
Both species were followed by SRM of the transitions m/z 746.6 → m/z 283.3 and m/z
746.6 → m/z 327.3 while the CV of the DMS was increased.
3.3.2.4 Discussion
The performed DMS experiments imply its use for shotgun lipidomics. It was particu-
larly helpful in cases where co-isolation of precursor ions by MS/MS adversely aﬀected
the assignment to molecular species. Thus, we could demonstrate the separation of
PE 18:0/18:0 and PE-O 16:0p/22:6 species. This might be possible with blood plasma
lipid such as PC 33:1 and PC-O 34:1 too and might allow to overcome ambiguities in
the fragment assignment.
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3.4 Fragmentation of glycerophospholipids by HCD
In mass spectrometry, fragmentation of molecular ions is induced by increase of the
internal energy as a consequence of collisions of the analyte ions and neutral gases.
The generated fragments are used to specify the identity of the analyte as well as its
quantity. In case of GPL, carboxylate ions are released upon CID in negative mode.
The quantiﬁcation of molecular lipid species based on carboxylate ions is an established
lipid analytics approach. In order to ensure accurate absolute quantiﬁcation, the in-
ternal standard and the lipid analyte of interest should exhibit (I) similar ionization,
important for MS based quantiﬁcation, and (II) similar fragmentation properties, in
case of DDA of MS/MS or FAS experiments (22). The second aspect is of greatest im-
portance for the quantiﬁcation of molecular lipid species by tandem MS. In this section,
I characterized the fragmentation of GPLs to specify their diﬀerences or similarities in
terms of carboxylate anion recovery. Particular attention was applied to species with
PUFAs.
3.4.1 Comparison of the fragmentation for PE 18:0/18:0 and PE-O
16:0p/22:6
Assuming that the GPLs with saturated FA moieties have similar fragmentation prop-
erties like their polyunsaturated homologues, PE 18:0/18:0 ([M − H]−, m/z 746.5696))
could be used to quantify PE-O 16:0p/22:6 ([M − H]−, m/z 746.5124) (32).
In this experiment, the breakdown of this lipid analytes was analyzed by HCD to
specify the recovery of their carboxylate ions and corresponding NL fragments. There-
fore, both lipids were analyzed in separate experiments on the Velos via direct infusion.
The conventional ESI source was selected to ensure spray stability with less then 10 %
deviation of TIC. The nCE was ramped from 0 % up to 120 % (CE = 89 eV).
The signal intensity for each peak of interest in proﬁle FT MS/MS(−) was speciﬁed
by integration of the signal using XCalibur software. The intensities of the carboxylate
ions (IFA) and speciﬁc NLs of CO2 and H2O (ICO2 , IH2O) were summarized and nor-
malized to the average intensity (within nCE 0 – 10 %) of the intact precursor (IM ) to
give the relative intensity of the summed carboxylate fragments (Irel, [%]).
Irel =
∑
(IFA + ICO2 + IH2O)
IM
∗ 100 (3.1)
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The determined breakdown curves of PE 18:0/18:0 and PE-O 16:0p/22:6 exhibited
distinct shapes (Figure 3.17 A). PE-O 16:0p/22:6 began to fragment at lower nCE
than PE 18:0/18:0. The maximum Irel of 48 % for [FA 22:6 − H]− (including the NL
fragments [FA 22:6 − H − CO2]− and [FA 22:6 − H − H2O]−) from PE-O 16:0p/22:6
was reached at nCE of 49 % (CE of 36 eV) and declined before the maximum Irel of
[FA 18:0 − H]− from saturated species PE 18:0/18:0 was reached (at nCE of 66 %;
CE of 49 eV). The point of intersection was at nCE of 44 %. Only at this nCE PE-O
16:0p/22:6 could be absolutely quantiﬁed without an error by saturated PE standards
such as PE 18:0/18:0. Otherwise emerges a nCE dependent error of quantiﬁcation (f).
f =
∣∣∣∣ Irel−xIrel−ref ∗ 100− 100
∣∣∣∣ (3.2)
Irel−x is the relative intensity of the carboxylate ions of a species of interest; Irel−ref
is the relative intensity of the carboxylate ions of the reference species; both at the
same nCE. In our case, PE-O 16:0p/22:6 would be systematically overestimated at
nCE below 44 % and underestimated at nCE above 44 % when saturated standards
are used for quantiﬁcation.
The observed discrepancy with previous publications (see Table 2 in (32)) was not
an artefact of the precursor isolation because (I) the breakdown tests compared only
isolated ion populations and (II) fragmentation caused losses have been reproducible on
QExactive instrument too (Figure 3.17 B). Further, no fragments that could balance
the losses were detectable on the Velos in HCD FT MS/MS(−) (Figure 3.18). The
increased relative intensity of the keten loss of FA 22:6 (at m/z 436.2830) is speciﬁc for
plasmenyl-PE.
The experiment shows that polyunsaturated GPL species fragment diﬀerently than
saturated species. Quantiﬁcation of both together would be possible only in a very
narrow nCE range (referring to PE 18:0/18:0 and PE-O 16:0p/226). Still, this nCE
range will be lipid class dependent.
Further should be noted, that [FA 22:6 − H]− can be only detected if nCE does not
exceed 75 %; irrespective of the lipid class.
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Figure 3.17: Breakdown of PE 18:0/18:0, PE 22:6/22:6 and PE-O 16:0p/22:6 by
HCD. – (A) PE 18:0/18:0 ([M − H]−, black empty dots) and PE-O 16:0p/22:6 ([M − H]−,
red empty dots) were fragmented by HCD on the Velos at R m/z 400 of 10.000 (FWHM).
Irel of [FA 18:0 − H]− (black dots) and [FA 22:6 − H]− (red dots). The diﬀerences of Irel
is expressed by the graph of error f . The dashed line at nCE of 65 % indicates the point
where the ratio of intensities for CO2 NL of [FA 22:6 − H]− and [FA 22:6 − H]− was about
0.56 (as in (32)). Each data point represents the average and SD of 3 experiments. (B)
Breakdown of PE 18:0/18:0 and PE 22:6/22:6 ([M − H]−) upon fragmentation by HCD
on the Velos (straight line) and QExactive (dashed line). Irel is reported for [FA 18:0 −
H]− (blank line) and [FA 22:6 − H]− (red line). Note: nCE set on QExactive corresponds
to the reported nCE value divided by 2.
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Figure 3.18: HCD FT MS/MS(−) of PE 18:0/18:0 and PE-O 16:0p/22:6. –
HCD FT MS/MS(−) for both standards was acquired at nCE of 5 % and 65 % on the
Velos. R m/z 400 was 10.000 (FWHM) for PE 18:0/18:0 and 40.000 for PE-O 16:0p/22:6.
The spectra of each species were normalized to the intensity of intact precursor (right zoom
panel).
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3.4.2 Fragments of polyunsaturated fatty acids
The previous experiment indicated that the fragmentation of [FA 22:6 − H]− is CE-
dependent. Here, I specify the identity and the relative abundance of its fragments. The
fragmentation analysis was performed for LPE 20:4 and LPE 22:6 (both detected as [M
− H]−) that contained the most abundant PUFAs: FA 20:4 and FA 22:6. CID and HCD
FT MS/MS(−) measurements were carried out on QStar and Velos instruments. In
both cases, nitrogen was used as collision gas, which led to comparable fragmentations.
The detection of small fragments with m/z below 100 was performed on QStar.
CID MS/MS(−) analysis on QStar instrument was performed with stepwise in-
creased CE of 20 to 50 eV. Upon CID, the precursor ions of LPE 20:4 ([M − H]−,
m/z 500.32) and LPE 22:6 ([M − H]−, m/z 524.28) yielded a variety of fragments
(Figure 3.19). The most abundant fragments at a low CE of 20 eV were the carboxy-
late ions ([FA 20:4 − H]− at m/z 303.23 and [FA 22:6 − H]− at m/z 327.26) and the
corresponding NL of CO2 (at m/z 259.23 and m/z 283.25). Further increase of the
CE caused the complete fragmentation of the precursor and an increase of the relative
abundance of carboxylate and head group corresponding fragment ions. At a CE of 40
to 50 eV the number and abundance of carboxylate ion fragments was clearly increased.
The intensity of the carboxylate ion was consequently decreased (see Figure 3.20 for
assignment). The acetate anion ([CH3COO]
–, at m/z 59.01) was the most intense car-
boxylate ion fragment in CID MS/MS on QStar. Larger head group fragments at m/z
140.02, 196.04 and 214.05 were also fragmented to give abundant phosphate (([PO3]
–,
m/z 78.96) and [H2PO4]
–, m/z 96.96) and the O-phosphorylethanolamine anions (at
m/z 140.02). Fragments smaller than m/z 50 were not detected on QStar. This ob-
servation was conﬁrmed for [LPE 20:4 − H]− and [LPE 22:6 − H]− by product ion
scanning on QqQ instrument TSQ Vantage.
The measurements of PUFA carboxylate anions showed a series of corresponding
fragment ions. Yet, their total intensity did not fully compensate fragmentation caused
intensity losses compared to saturated homologues.
For clariﬁcation consider the intensity of the carboxylate anion fragments of [LPE
22:6 − H]−, detected on the QStar at 30 eV (Figure 3.19). The sum of all [FA 22:6 −
H]− carboxylate ion fragments was 1.2 times higher than the sum of [FA 22:6 − H]−
and its speciﬁc CO2 and H2O NLs. Thus, 20 % of carboxylate ion intensity would be
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Figure 3.19: The relative abundance of fragment ions detected in CID
MS/MS(−) of LPE 20:4 and LPE 22:6 on QStar instrument. – (A) LPE 20:4
and (B) LPE 22:6 (both measured as [M − H]−) was fragmented by CID on QStar in-
strument. The CE was increased in steps from 20 to 50 eV. Fragment intensities were
extracted from generated peak list ﬁles. The fragment intensities were normalized to the
sum intensity of all detected fragments ( Figure 3.20 for structural assignment). Intensities
represent the average of 10 MS/MS(−) spectra per CE.
neglected if only the latter, the speciﬁc fragments, are considered for quantiﬁcation.
However, the intensity diﬀerence detected for PE-O 16:0p/22:6 and PE 18:0/18:0 at
55 % nCE (Figure 3.17, where similar fragment rations existed (LPE 22:6 / PE-O
16:0p/22:6: 100 / 100 (m/z 327.3); 62 / 59 (m/z 283.3); 10 / 10 (m/z 229.2) and 4 /
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3 (m/z 177.2)), was about 45 %. 45 % is unequal to 20 %.
Multiple carboxylate anion fragments were detected for PUFA. This observation
matches to previous publications (62). Of these, only the carboxylate anion, its CO2
and H2O loss are speciﬁc. All other fragments are unspeciﬁcity (Figure 3.19) or limited
detectable. Estimations that included all carboxylate ion fragments did not lead to
adequate compensation of fragmentation caused losses.
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Figure 3.20: Fragments of LPE 22:6 observed in CID MS/MS(−). – Assumed
structural formulas of the most abundance fragment ions observed for LPE 22:6 ([M −
H]−).
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3.4.3 Eﬀect of fatty acid double bounds on the carboxylate ion reco-
very
The previous experiment elucidated reduced recovery of PUFA carboxylate anions as a
consequence of CID fragmentation. This raised questions about the absolute quantiﬁ-
cation of corresponding GPL species. Because there exists no systematic description or
theoretical model for the breakdown of GPL (under various conditions), it is impossi-
ble to predict the quantitative diﬀerences and the quantiﬁcation error. For this reason,
a set of PC and PC-O was synthesized that comprised all major FAs of mammalian
systems. The breakdown of these lipid species was analyzed by HCD FT MS/MS(−)
on the Velos.
Note: Sn-1 and sn-2 FAs were handled separately to determine the eﬀect of CID
on the recovery of carboxylate ions from PCs. Summarization of their Irel could lead
to an error of judgment.
Closer examination of PC breakdown shows that with an increasing number of
double bounds Iref decreased at increased nCE (Figure 3.21). None of the PUFA
Irel curves had suﬃcient accordance with their saturated homologues. The strongest
fragmentation and the lowest recovery was observed for [FA 22:6 − H]− (4z). The
fragmentation diﬀerences of polyunsaturated PC could be reproduced for plasmanyl
PC species (Figure 3.22). Aside from the number was the recovery or Irel dependent
on the position of the double bonds. The fragmentation of the precursor and of the
PUFA carboxylate anions started at lower nCE, the closer the double bounds were
relative to the carboxyl group (Figure 3.21, bottom left panel). Even Irel of positional
isomers [FA 22:5 − H]− (4z) and [FA 22:5 − H]− (7z) diﬀered clearly for both PC and
PC-O (Figure 3.23 and Figure 3.24).
The comparison of the fragmentation of diﬀerent polyunsaturated PC and PC-O
species clariﬁed their distinct behavior under CID. It has been shown that number and
position of double bounds are considerable inﬂuencing variables.
57
3. RESULTS AND DISCUSSION
 PC 16:0  18:0
 PC 16:0  18:1 (9z)
 PC 16:0  18:2 (9z)
 PC 16:0  18:3 (9z)
Re
l. 
in
te
ns
ity
, %  PC 16:0  20:0
 PC 16:0  20:3 (8z)
 PC 16:0  20:4 (5z)
 PC 16:0  20:5 (5z)
Norm. collision energy, %
 PC 16:0  22:0
 PC 16:0  22:4 (7z)
 PC 16:0  22:5 (4z)
 PC 16:0  22:5 (7z)
 PC 16:0  22:6 (4z)
Variable carboxylate ion [FA 16:0]-
0 10 20 30 40 50 60 70 80 90 100 110 120
0
10
20
30
40
50
0 10 20 30 40 50 60 70 80 90 100 110 120
0
10
20
30
40
50
0
10
20
30
40
50
0
10
20
30
40
50
0
10
20
30
40
50
0
10
20
30
40
50
0 10 20 30 40 50 60 70 80 90 100 110 1200 10 20 30 40 50 60 70 80 90 100 110 120
0 10 20 30 40 50 60 70 80 90 100 110 1200 10 20 30 40 50 60 70 80 90 100 110 120
 
Figure 3.21: Carboxylate ion recovery from polyunsaturated PC species. –
PC 16:0 ∼ x:y species were analyzed by HCD FT MS/MS(−) on the Velos at R m/z 400 of
10.000 (FWHM). nCE was stepwise increased from 0 to 119 %. Irel of variable FA moieties
([M − H]−) were reported in the left; Irel of [FA 16:0 − H]− in the right column. Average
and SD are reported for 3 experiments.
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Figure 3.22: Carboxylate ion recovery from polyunsaturated PC-O species. –
PC-O 16:0e/x:y species were analyzed by HCD FT MS/MS(−) on the Velos. Irel of [FA
x:y − H]− (ﬁled dots) represents the average and SD of 3 experiments. The diﬀerences of
Irel was expressed by the graph of error f .
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Figure 3.23: Carboxylate ion recovery from PC-O 16:0e/22:5 isomers. – PC-O
16:0e/22:5 (4z) and PC-O 16:0e/22:5 (7z) were analyzed by HCD FT MS/MS(−) on the
Velos at R m/z 400 of 80.000 (FWHM). Irel of [FA x:y − H]− (ﬁled dots) represents the
average and SD of 3 experiments. The diﬀerences of Irel was expressed by the graph of
error f .
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Figure 3.24: Relative intensity of carboxylate ion fragments of 22:5 isomers. –
PC-O 16:0e/22:5 (4z) and PC-O 16:0e/22:5 (7z) were analyzed by HCD FT MS/MS(−)
on the Velos at R m/z 400 of 80.000 (FWHM). Irel of [FA x:y − H]− (ﬁled dots) represents
the average and SD of 3 experiments. The relative sum intensity of CO2 and H2O to intact
precursor is shown by empty dots. Their relative intensity to the carboxylate ion [FA 22:5
− H]− is shown in the lower panel.
61
3. RESULTS AND DISCUSSION
3.4.4 Impact of the acyl chain length on the carboxylate ion recovery
Before, I described that the normalization of the CE on the Orbitrap instruments com-
pensated the mass dependency of the CE. Correspondingly, the maximum carboxylate
ion intensity Irel for PCs with diﬀerent saturated FA moieties was found within a nar-
row nCE range of 65 ± 3 %. Yet, the lipid standards carboxylate ion recovery was only
approximately equal (Figure 3.9).
Thus, I detected an error f of more than 10 % when nCE was above 50 % and PC
18:0/18:0 was used as reference standard for the quantiﬁcation PC 12:0/12:0 (Figure
3.25). PC 14:0/14:0 showed a tendentially similar behavior whereas the error f was
lower.
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Figure 3.25: Comparison of the carboxylate ion recovery for PC 12:0/12:0, PC
14:0/14:0 and PC 18:0/18:0. – Diﬀerent PC species (measured as [M + HCOO]−) were
fragmented by HCD on the Velos at R m/z 400 of 10.000 (FWHM). The nCE was ramped
from 0 to 120 %. The diﬀerences of Irel for [FA 12:0 − H]− and [FA 14:0 − H]−, respective
to [FA 18:0 − H]−, is expressed by the graph of error f . Each data point corresponds to
the average and SD of 3 experiments.
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The detected carboxylate ion recoveries for diﬀerent saturated PC species indicated
a potential dependency on the acyl chain length. This should be considered for samples
with FAs varying by more then ± 4 carbons, which occurs in most biological samples.
FFA with total carbons from 12 to 24 were described for blood plasma (see Suppl. Table
1A in (10)). Even larger variety of FA moieties has been detected in retina PCs, where
the total number of carbons ranged from 14 to 36. In consideration of the biological
variability of the alkyl chain length, an inﬂuence on the carboxylate ion recovery would
be likely but remains to be investigated in detail.
3.4.5 Carboxylate ion recovery for diacyl-, plasmanyl- and plasmen-
yl-PC species in comparison
The comparison Irel for PE 18:0/18:0 and PE-O 16:0p/22:6 raised the question, whether
diacyl-GPLs are valid standards for the quantiﬁcation of their plasmenyl-/plasmanyl-
homologues. To this end, the breakdown of PC 16:0/16:0 and PC-O 16:0e/16:0 was
studied by HCD FT MS/MS(−) on the Velos.
The fragmentation for PC 16:0/16:0 and PC-O 16:0/16:0 (both measured as [M +
HCOO]−) by HCD resulted thereby in diﬀerent Irel for [FA 16:0 − H]− (Figure 3.26).
At nCE below 60 % Irel or the recovery for both standards diﬀered by more than 10
%.
In this context, I further compared the fragmentation of plasmanyl-/plasmenyl-
PCs, i.e. PC-O 16:0e/20:4 and PC-O 16:0p/20:4 ([M + HCOO]−) (Figure 3.27). In
both cases I obtained similar Irel: within a nCE range of 50 % to 110 % the recoveries
diﬀered by less than 10 %.
These data illustrate that a quantiﬁcation of plasmanyl-/plasmenyl-GPLs via satu-
rated diacyl-GPLs leads to a systematic error of quantiﬁcation at low nCE. The use of
a separate synthetic standard would be therefore of advantage. Note: The data shown
for plasmenyl-GPLs do not include the FA-O fragment. Its intensity was negligible at
nCE below 60 %. Plasmanyl-GPLs did not generate this fragment at all, which was in
accordance with previous publications (Figure 3.28) (52).
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Figure 3.26: Breakdown of PC 16:0/16:0 and PC-O 16:0e/16:0. – HCD FT
MS/MS(−) with ramping nCE from 0 % to 119 % were acquired by direct infusion on the
Velos at R m/z 400 of 10.000 (FWHM). The diﬀerences of Irel for [FA 16:0 − H]− from
PC 16:0/16:0 and PC-O 16:0/16:0 is expressed by the graph of error f . Each data point
represents to the average and SD of 3 experiments.
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Figure 3.27: Carboxylate ion recovery from plasmanyl- and plasmenyl-PC. –
PC-O 16:0e/20:4 and PC-O 16:0p/20:4 ([M + HCOO]−) were fragmented by HCD FT
MS/MS(−) on the Velos at R m/z 400 of 10.000 (FWHM). The nCE was ramped from 0 to
120 %. The diﬀerences of Irel for [FA 20:4 − H]− (incl. NLs) is expressed by the graph of
error f . Each data point corresponds to the average and SD of 3 experiments.
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Figure 3.28: HCD FT MS/MS(−) of PC-O 16:0e/20:4 and PC-O 16:0p/20:4.
– Spectra for PC-O 16:0e/20:4 (A) and PC-O 16:0p/20:4 (B) were acquired on Velos by
HCD at nCE of 75 % nCE. The zoom shows the relative intensity of the FA-O fragment.
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3.4.6 Inﬂuence of carboxylate ion fragmentation on the quantiﬁcation
of molecular lipid species
The preceding experiments elucidated discontinuity in fragmentation of polyunsatu-
rated GPLs in comparison to their saturated homologues. To substantiate my observa-
tion, I analyzed a mixture of commercial PE and plasmenyl-PE species by DDA of HCD
FT MS/MS(−) as previously described (Section 3.2). The MS/MS(−) of the analytes
were acquired at diﬀerent nCE (45 to 75 %). Generated raw data were analyzed for each
nCE separately by LipidXplorer software. PE 18:1/18:1 was the reference standard for
FT MS(−) and FT MS/MS(−) data. Lipidomics proﬁles obtained from FT MS/MS(−)
data were normalized to FT MS(−) data to expose the eﬀect of fragmentation. Brieﬂy,
I made a comparison of the lipidomics proﬁles whereas concentration diﬀerences were
eliminated.
In this experiment I could demonstrate that via nCE the lipidomics result can be
biased (Figure 3.29). I retrieved a systematic error of quantiﬁcation for short chain
species PE 12:0/12:0 and PE 14:0/14:0, as previously observed for PC, and for polyun-
saturated PE (PE 18:0/22:6 and PE 22:6/22:6) and PE-O (PE-O 16:0p/20:4 and PE-O
16:0p/22:6) species.
The performed DDA experiment did not provide a statement on the impact of
quantiﬁcation regarding diﬀerent lipid classes. I tried to assess their impact on the
’optimal’ nCE by analyzing a set of LPE and LPI standards. The point of intersection
of Irel or of the minimized error of quantiﬁcation for saturated and polyunsaturated
species of diﬀerent classes was distinct as well. Irel for LPE 16:0 and LPE 20:4 was
identical at nCE of 57 % while Irel for LPI 16:0 and LPI 20:4 was the same at nCE of
69 %.
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Figure 3.29: Changes of the lipidomics proﬁle upon increase of the collision
energy. – A mixture of PE species at diﬀerent concentrations was measured by DDA of
HCD FT MS/MS on the Velos. MS/MS(−) were acquired 4 times for each species at nCE
45/55/65/75 %. Intensities of FT MS(−) and FT MS/MS(−) were normalized to internal
standard PE 18:1/18:1 ([M − H]−). The resulting proﬁle of FT MS was used as reference
to normalize FT MS/MS(−) data. The average, relative standard deviation for FT MS(−)
data was 3.4 % and 11.2 % for FT MS/MS(−).
68
3.4 Fragmentation of glycerophospholipids by HCD
0 10 20 30 40 50 60 70 80 90 100 110 120
Norm. collision energy, %
0
25
50
75
100
Er
ro
r, 
%
LPE 20:4 re LPE 16:0
LPI 20:4 re LPI 16:0
0
10
20
30
40
50
60
70
80
90
100
Re
l. 
in
ten
sit
y,
 %
 precursor ion
 carboxylate ion (incl. NLs)
LPI 20:4
LPI 16:0
LPE 16:0
LPE 20:4
Figure 3.30: Carboxylate ion recovery from LPE and LPI. – LPE 16:0, LPE 20:4,
LPI 16:0 and LPI 20:4 ([M − H]−) were fragmented by HCD FT MS/MS(−) on the Velos
at R m/z 400 of 10.000 (FWHM). The nCE was ramped from 0 to 120 %. The diﬀerences of
Irel for [FA 20:4 − H]− (incl. NLs) is expressed by the graph of error f . Each data point
corresponds to the average and SD of 3 experiments.
69
3. RESULTS AND DISCUSSION
3.4.7 Fragmentation of polyunsaturated species under ion trap CID
After demonstrating the impact of CID on carboxylate ion recovery and hence on the
quantiﬁcation of molecular lipid species, I tested the impact of commonly used linear ion
trap CID MS/MS(−) too. Therefore, additional IT CID FT MS/MS(−) measurements
of PC 16:0/16:0 and PC 16:0/22:6 ([M + HCOO]−) were performed.
Here, I observed that the carboxylate ion recovery from polyunsaturated PC 16:0/22:6
was also reduced (Figure 3.31). The discrepancy in the ion recovery was above 40 %
at any nCE in IT CID FT MS/MS(−) compared to PC 16:0/16:0. The performed IT
CID FT MS/MS(−) revealed that carboxylate ions of PUFA also fragment under IT
CID MS/MS(−). In corresponding lipidomics experiments the discrete fragmentation
of lipid analytes should be considered as well.
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Figure 3.31: Carboxylate ion recoveries from PC 16:0/16:0 and PC 16:0/22:6
under ion trap CID MS/MS(−). – PC 16:0/16:0 and PC 16:0/22:6 were analyzed by
CID FT MS/MS(−) on the Velos at R m/z 400 of 80.000 (FWHM). The nCE was ramped
from 0 to 119 %. The Iref represents the average and SD of 3 experiments.
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3.4.8 Discussion
The fragmentation behavior of polyunsaturated GPLs was analyzed and it was found,
that their quantiﬁcation by their saturated homologues leads to systematic errors. The
error was more serious at higher nCE (above 55 %), where the sensitivity of saturated
carboxylate ions is generally increased. Considering of CO2 and H2O NL fragments did
not compensate fragmentation caused intensity losses for polyunsaturated lipid species.
Nevertheless, systematic errors were also found at lower nCE (e.g. of 45 %, Table 3.5).
Table 3.5: Systematic errors of quantiﬁcation at nCE 45 %. – The error f was
estimated based on fragmentation data determined by HCD FT MS/MS(−) on the Velos.
Reference Lipid Error f , %
standard species
PE 18:0/18:0 PE 18:0/18:1 ≤ 10
PE-O 16:0p/22:6 ≤ 10
PE 22:6/22:6 ≈ 25
PA 18:0/18:0 PA 16:0/22:6 ≈ 50
PC 18:0/18:0 PC 12:0/12:0 ≈ 50
PC 16:0/16:0 PC-O 16:0e/16:0 ≈ 45
PC-O 16:0e/18:0 ≈ 45
PC-O 16:0e/16:0 PC-O 16:0e/18:0 ≤ 10
PC-O 16:0e/22:5 (4z) ≈ 25
PC-O 16:0e/22:5 (7z) ≤ 10
PC-O 16:0e/22:6 (4z) ≈ 25
PC-O 16:0e/20:4 PC-O 16:0p/20:4 ≈ 15
Since there is no ’optimal’ nCE, accurate absolute quantiﬁcation requires the appli-
cation of correction factors to consider for discrete fragmentation diﬀerences in MS/MS.
The achieved fragmentation data of synthesized PC and PC-O standards can help to
estimate the factors for other lipid classes.
My data contradict previous assumptions in parts. Yet, they ﬁt to others obser-
vations (e.g. to Yang et al. (62)) and could explain deviations in previously reported
data (e.g. Figure 5 A and C of (34) (compare the ratio of PE 38:4 and PE 36:2)).
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3.5 Biological and medical applications
Contributions
Following project were enabled and supported by the preliminary work of other scien-
tists, for which they are mentioned here by name.
  Blood plasma samples for lipidomics screens were selected and provided by Prof.
Dr. Ju¨rgen Gra¨ssler (Project 3.5.1, 3.5.3) and Dr. Steﬃ Kopprasch (Project
3.5.2), respectively. Both also realized statistic and clinical evaluation of the
lipidomics data.
  Lipoprotein fractionation was performed by Sigrid Nitzsche (Project 3.5.1).
  Blood plasma samples for investigation of the correlation of FABP4 and lipid
levels in human were selected and provided by Dr. Valeria Zepter (Project 3.5.3).
  The preparation, in vivo and in vitro experiments with pancreatic islets were
designed and performed by Dr. Barbara Ludwig (Project 3.5.4) with support by
Anja Steﬀen.
  Maradolipids were provided by Dr. Sider Penkov (Project 3.5.5).
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3.5.1 Lipid apheresis and the isolation of lipoproteins
One of the main risks for cardiovascular events are sclerotic changes of the blood ves-
sels that are triggered among others by hypercholesterolemia (63). Severe forms of
this metabolic disorder can be medicated only insuﬃciently by drug treatment and
dietary intervention. The ablation of excess cholesterol and an improved prognosis for
the patient (64, 65) is then achieved by selective removal of low density lipoprotein
(LDL) using apheresis. Extracorporeal applied methods that are used in apheresis to
gain separation of lipid particles are based on size exclusion, selective adsorption and
precipitation (66).
Here we applied the established shotgun lipidomics approach to investigate the
impact of apheresis on the molecular lipid composition of blood plasma. Furthermore,
the experiments aimed at the direct analysis of distinct lipoprotein fractions which
required the adaptation of separation protocol to the electrospraying conditions.
3.5.1.1 Lipidomics changes upon lipid apheresis: a case study
In this trail, a patient (anthropometric characteristics: age = 70 y, weight = 78.6 kg,
height = 1.78 m, Waist-to-hip ratio (WHR) = 1.03) was subjected to apheresis. In
a ﬁrst step, the cellular components and the blood plasma were extracorporeal sepa-
rated, followed by sequential removal of very-low density lipoprotein (vLDL), interme-
diate density lipoprotein (IDL), LDL, lipoproteins(a) (LDL-like particle with attached
apolipoproteins (a)) and ﬁbrinogen by size exclusion. The combined cellular compo-
nents and the reduced blood plasma were returned to the patient.
Blood samples from this patient were obtained before, directly after and 3 d after
apheresis. The blood plasma was isolated and subjected to lipidomics analysis to
monitor induced lipid compositional changes.
In parallel determined clinical lipid parameter (Table 3.6) indicate a reduction of
the total cholesterol (TC) by 1.79 mM or −48.4 % , total triacylglycerol (TG) by 1.1
mM or −67.1 % and LDL cholesterol (LDL-C) by 1.24 mM or −70.1 %. HDL particles
were slightly aﬀected and caused a minor reduction of HDL cholesterol by 0.19 mM or
−13.5 % was observed. These data are consistent with the indications of the apheresis
manufacturer.
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Figure 3.32: Alteration of the blood plasma lipid composition by size exclusion
apheresis. – (A) Lipid class composition of a patients blood plasma before, directly after
and 3 d after apheresis as determined by shotgun lipidomics. The detailed concentration
values are reported in the appendix (Table A-5). Concentrations are speciﬁed by the
average and SD of 2 technical replicates, (B) Percentage change of lipid concentration
compared to the level before apheresis.
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Table 3.6: Eﬀect of size exclusion apheresis on common lipid parameters. - Total
cholesterol (TC), triglycerides (TG), LDL-cholesterol (LDL-C), HDL-cholesterol (HDL-C),
and lipoprotein(a) (Lp(a)) were determined for the blood plasma (1) before, (2) after and
(3) 3 d after LDL apheresis.
Sample TC, Change, TG, Change, LDL-C, Change, HDL-C, Change, Lp(a), Change,
mM % mM % mM % mM % mM %
1 3.70 1.64 1.77 1.42 1192
2 1.91 -48.4 0.54 -67.1 0.53 -70.1 1.23 -13.4 296 -75.2
3 3.26 -11.9 1.23 -25.0 1.40 -20.9 1.64 +15.5 866 -27.3
The shotgun lipidomics analysis of the same blood plasma samples revealed a num-
ber of changes that are not covered by common lipid parameters (Figure 3.32). I
observed an almost complete removal of LPC-O and a reduction by more than 50% for
lipid classes CholE, DAG, PC, PC-O, PI, SM and Cer after apheresis. In contrast, the
levels of LPC, PE and PE-O were reduced only between 20 to 50 %. LPE was found
to be even increased by more than 20 % in this patient.
3.5.1.2 Shotgun lipidomics analysis of lipoprotein fractions
In order to achieve a direct veriﬁcation of the reduction of speciﬁc lipoproteins by
apheresis and a more detailed insight into the metabolism, the fractionation lipopro-
tein particles contained by blood plasma might be important. A common preparative
method is their separation by ultracentrifugation in buﬀer solutions with gradual in-
creased density. The density of aqueous solutions is thereby increased through addition
of sodium and/or potassium salts (67).
In a trail, the lipoproteins from the blood plasma of an unspeciﬁed patient were
prepared by the routine protocol that utilizes a NaCl/NaBr density buﬀer. The total
lipid extracts of corresponding lipoproteins were generated using the MTBE recipe (56)
and subsequently analyzed by direct infusion on the LTQ Orbitrap XL in positive mode
(18) (Figure 3.33).
The shotgun lipidomics analysis revealed a majority of CholE and SM in LDL with
more than 50 % of their total in blood plasma. Further, the majority of TAG was
found with more than 70 % of its total in vLDL particles. Other main components
of the blood plasma PC, PC-O, PE and PE-O were found in equal shares within the
lipoproteins. A minor proportion of monoacyl lipid species LPC and LPE was found
within the analyzed lipoprotein fractions. Their majority is bound to albumin and
other fatty acid binding proteins (68), which were not analyzed.
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The observed quantities and ratios of the lipid classes are in good agreement with
the previous results (44). However, measurements of the same total lipid extracts in
negative ion mode and thus the determination of molecular GPL species failed as a
consequence of contamination with sodium salts.
CholE PC-O PE-O
Figure 3.33: Lipid composition of human lipoproteins. – Lipoproteins fractions
were prepared by NaCl/NaBr density gradient, extracted MTBE/MeOH and analyzed by
direct infusion high resolution FT MS(+).
3.5.1.3 Optimization of lipoprotein fractionation for shotgun lipidomics
Shotgun lipidomics analysis of lipoprotein fractions directly after their extraction could
be enabled only when the concentration of disturbing interferences remained low. In
this context, I tested a protocol published by Hallberg et al. that used D2O (density ρ
of 1.107 g/cm3) and worked at physiological salt concentrations (69). The protocol was
adapted for a trail experiment in which NaCl was substituted by ammonium formiate.
For the trail, an unspeciﬁed human blood plasma sample was unstitched into its
lipoproteins components by the established NaCl/NaBr and the modiﬁed D2O protocol.
76
3.5 Biological and medical applications
Fractions obtained by NaCl/NaBr protocol contained increased amount of salts; 0.19
M NaCl plus 0 M NaBr for vLDL, 0.78 M NaBr for LDL or 3.02 M NaBr for HDL
and residue, respectively. Lipoprotein fractions obtained via D2O protocol contained
the salts solved in the plasma plus 0.15 M ammonium formiate. The consequent salt
content of the vLDL fraction was similar and more than 5 times lower for LDL and
HDL containing residue.
For veriﬁcation of the D2O lipoprotein fractionation, the standard lipid parameter
TC and TG were determined and compared to the values obtained for fractions pre-
pared according to the established protocol. The enzymatically determined values were
identical within an experimental error of less than 10 % for both preparations (Figure
3.34).
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Figure 3.34: Total cholesterol and TAG composition of lipoprotein fractions
obtained by D2O and established NaCl/NaBr protocol. – Total cholesterol (TC)
and total triacylglycerol (TG) concentrations of prepared lipoprotein fractions were enzy-
matically determined for the prepared lipoprotein fractions vLDL, LDL and HDL.
Total lipid extracts of the lipoproteins from both preparations were measured by
shotgun lipidomics. The FT MS(−) analysis of extracts obtained from NaBr containing
lipoprotein fractions, especially LDL and HDL, was disturbed by the high salt content
of the lipid extracts as mentioned above (Figure 3.35 A). In contrast, the analysis of
lipoproteins obtained by D2O protocol was undisturbed such that FT MS(−) measure-
ments could be performed (Figure 3.35 B). A possible remaining jamming source of
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the lipid extraction and MS analysis might be the modiﬁer added to the blood plasma.
Among others, 10.5 mg sucrose were added to 1.5 ml plasma, which equals to a con-
centration of approximately 20.5 mM. Due to its solubility in alcohols, I could detect
the formiate adduct of sucrose ([M + CH3COO]
−, m/z 387.1153) in the FT MS(−)
spectrum of the total extract.
In summary, the fractionation using D2O allowed to obtained lipoproteins with
minor salt contamination such that the shotgun lipidomics approach could be directly
applied.
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Figure 3.35: Comparison of FT MS(−) spectra of HDL lipoprotein fractions
obtained by NaCl/NaBr and D2O protocol. – HDL fraction prepared via NaCl/NaBr
and D2O protocol were extracted by MTBE/MeOH and measured via direct infusion MS.
FT MS(−) spectra for the extracts from the (A) NaCl/NaBr and (B) D2O preparations
were acquired on LTQ Orbitrap XL.
3.5.1.4 Discussion
An alternative lipoprotein fractionation protocol that used D2O has been adapted and
showed compatibility to the previously established shotgun lipidomics routines. It
enabled the preparative puriﬁcation of lipoproteins. A separation of HDL and free
plasma proteins as via NaCl/NaBr protocol was not possible. If desired, plasma proteins
might be depleted by additional immuno-puriﬁcation. The addition of sucrose to the
buﬀer to achieve a further increase of the buﬀer density (50 % w:w sucrose in water, as
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described by St˚ahlman et al. (70)) could be also tested but might lead to complication
of the lipid extraction and MS analysis due to molar concentrations of sucrose.
The tested protocol would enable a detailed analysis of lipoproteins from blood
plasma and would be beneﬁcial, amongst others, for the investigation of speciﬁc changes
of the plasma lipidome by apheresis treatment. By this means the removal of certain
lipoprotein lipids could be directly followed and studied. Blood plasma lipidomics
changes caused by apheresis were shown and found to be in agreement with manufac-
turers data. Yet, since only blood plasma samples were analyzed the removal and the
recovery of certain lipoproteins was not directly attested by the measurements. The
latter might be helpful to understand the lipid ﬂux in human with greater detail.
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3.5.2 Alteration of the plasma lipidome in consequence of impaired
glucose metabolism
Diet and nutritional status of individuals play an important role in the T2D progres-
sion. In particular, the total amount and intake of fat increases the risk of developing
impaired glucose regulation and T2D (71). The excess of lipids is reﬂected in the blood
plasma composition. Within this study, we attempted to quantify the alteration of the
blood plasma lipids of humans with impaired glucose metabolism.
3.5.2.1 Eﬀect of impaired glucose metabolism on generic clinical parame-
ters
The study comprised 56 men. Anthropometric data and common biochemical parame-
ter were determined for each patient (Table A-7). The patients were grouped based
on insulin resistance or sensitivity indices (homeostasis model assessment (HOMA),
insulin sensitivity index (ISI), glucose insulin sensitivity index (GSI), and disposition
index (DI)).
In comparison to control, patients with impaired glucose tolerance (IGT) and T2D
individuals exhibited signiﬁcant elevated levels of glycated hemoglobin (HbA1c, 5.2 ±
0.1 vs. 5.7 ± 0.1 and 6.3 ± 0.1 [%]) (Table A-7). Both groups had elevated 2 h plasma
glucose (5.23 ± 0.26 vs. 8.96 ± 0.25 and 11.32 ± 0.73 [mM]), insulin (182.9 ± 29.5
vs. 560.9 ± 62.0 and 569.6 ± 81.5 [pM]) and C-peptide (2357 ± 177 vs. 3971 ± 301
and 3485 ± 235 [pM]) levels that indicated peripheral insulin resistance. As typical for
T2D, we found in this group further elevated levels of glucose (5.24 ± 0.09 vs. 6.86 ±
0.23 [mM]) and insulin (70.0 ± 7.1 and 138.7 ± 24.5 [pM]) under fasting conditions.
Common lipid metabolic parameters, including TC, TG, FFA, LDL-C and HDL
cholesterol (HDL-C), were not signiﬁcantly diﬀerent between control, IGT and T2D
group. Remarkably, patients of the control group were younger and had a signiﬁcantly
lower waist-to-height ratio (WHtR) than patients of IGT and T2D group.
3.5.2.2 Alteration of the lipidome due to impaired glucose metabolism
Lipidomics analysis of blood plasma samples from fasting state was performed as above
described whereas FT MS measurements of both polarities were performed in separate
experiments. In total I was able to quantify 172 lipid species of 12 lipid classes in
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the plasma of all patients with a retrieval rate of 90 %. The observed diﬀerences are
depicted in the Figure 3.36.
Figure 3.36: Alteration of the blood plasma lipidome due to impaired glucose
metabolism. – Concentration of lipid classes was calculated from the sum of the quantiﬁed
lipid species. The measured values are reported in Table A-6. Data are represented by the
average and standard error of means (SEM) of two technical replicates. The signiﬁcance
of diﬀerence is indicated.
T2D patients had signiﬁcant decreased plasma levels of CholE and PC-O. Similar,
IGT individual revealed lower CholE compared to control. Signiﬁcant diﬀerences are
attributable to individual lipid species of CholE and PC-O (Table 3.7).
3.5.2.3 Association of plasma lipidome alterations with clinical indices
In a further step, the lipid analytes were analyzed concerning their association to a
series of clinical indices.
Here we observed that total PC-O was negatively correlated with BMI, WHtR, FFA,
circulating insulin measures (proinsulin, C-peptide, insulin) and systemic inﬂammatory
parameters (C-reactive protein, leukocytes), and positively with HDL cholesterol. For
CholE we obtained similar correlations with exception of inﬂammatory values.
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Total concentration of lipid classes in blood plasma as well as individual molecular
lipid species showed diﬀerent associations to diﬀerent insulin sensitivity indices. Most
signiﬁcant were the positive associations between GSI and total PC-O, CholE, PE-O,
LPC and SM. Furthermore, HOMA was signiﬁcantly positive associated with total TAG
levels and negatively correlated with PC-O level. In case of ISI we observed opposite
trends.
Close association between insulin sensitivity markers was also observed when eva-
luating the correlation to individual molecular species. For instance, HOMA was sig-
niﬁcantly positively associated with 39 distinct individual TAG species.
Table 3.7: Age- and BMI-adjusted diﬀerences in CholE and PC-O between
control, IGT and T2D. - Data are represented by the average concentration and SEM
for each group.
Lipid specie Concentration,  M
Control IGT T2D
CholE 7373 ± 303 6019 ± 272 5849 ± 310 0.004
CholE 18:2 4032 ± 168 2895 ± 151 2980 ± 172 <0.001
CholE 18:3 190 ± 15 149 ± 14 121 ± 15 0.019
CholE 19:1 3.9 ± 0.5 3.7 ± 0.4 1.8 ± 0.5 0.006
CholE 20:2 5.5 ± 0.6 4.0 ± 0.5 1.5 ± 0.6 <0.001
CholE 22:5 4.0 ± 0.5 3.7 ± 0.4 2.1 ± 0.5 0.020
PC-O 112 ± 6 101 ± 6 87 ± 6 0.035
PC-O 32:0 2.0 ± 0.2 1.5 ± 0.2 1.1 ± 0.2 0.004
PC-O 34:1 4.5 ± 0.3 3.8 ± 0.2 3.2 ± 0.3 0.008
PC-O 34:2 9.1 ± 0.6 7.3 ± 0.5 6.2 ± 0.6 0.011
PC-O 34:3 9.2 ± 0.5 7.1 ± 0.5 5.7 ± 0.6 0.001
PC-O 36:2 2.2 ± 0.2 1.5 ± 0.2 1.1 ± 0.2 <0.001
PC-O 36:3 6.4 ± 0.5 5.0 ± 0.4 4.1 ± 0.5 0.007
3.5.2.4 Discussion
Within this study we detected that subjects with IGT and T2D exhibited signiﬁcant
decreased circulating CholE (lipid class and ﬁve species) and PC-O (lipid class and six
species) compared to control individuals. The analytes were of close correlation with
insulin resistance index (HOMA), glucose sensitivity index (GSI), and insulin sensitivity
index (ISI).
Negative correlation of obesity measures and positive association of total CholE with
the insulin and glucose sensitivity marker ISI and GSI, indicated their potential bene-
ﬁcial role for the glucose homeostasis. CholE 18:2 and CholE 20:2 were the individual
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CholE species that best discriminated between control, IGT and T2D individuals.
The circulating levels of PC-O in T2D patients were diminished compared to control
subjects. Their detailed correlation analyses further revealed a pattern of individual
PC-O species with shorter (C32 to C36) FA moieties with 0 to 3 double bonds that
were associated with higher insulin sensitivity as estimated by ISI. This observation
was in accordance with results from Pietila¨inen et al. (45). In addition, PC-O levels
were negatively associated with the plasma inﬂammatory markers leukocyte count and
C-reactive protein suggesting also an anti-inﬂammatory role for PC-O.
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3.5.3 Association of FABP4 and the plasma lipid composition
The dysregulation of the lipid metabolism is assumed to cause systemic disruption of
the insulin action and glucose metabolism as observed in the metabolic syndrome (72).
In this aspect, it is of interest to ﬁnd lipids that are active in the glucose homeostasis.
FA 16:1 (z9), derived from de novo FA synthesis, might be one of these regulators as
indicated by the analysis of a fatty acid binding protein 4 (FABP4) knock-out mice
model. Apart from the enzymes related to FA synthesis (such as stearoyl-Coenzyme A
desaturase 1 (SCD-1), fatty acid synthase (FAS)) FA 16:1 (z9) was found to regulate
the expression of cytokines (such as monocyte chemotactic protein-1 (MCP-1), tumor
necrosis factor-α (TNFα) and others) in adipose tissue and peripheral insulin signaling.
Within this experiment, I tried to examine whether the blood plasma lipidome is
altered upon enhanced FAPB4 expression in humans and a decrease of FA 16:1 (z9)
or a general eﬀect in the level of the other FABP4 substrates (FA 16:0, FA 18:0, FA
18:1 (73)) can be detected. The FA composition of individual lipid classes in blood
plasma was determined by DDA of HCD FT MS/MS on LTQ Orbitrap Velos as above
described (Section 3.2).
3.5.3.1 Lipidomics changes in patients with altered FABP4 blood plasma
levels
A ﬁrst analysis of lipidomics data was performed for a subset of healthy patients having
diﬀerent FABP4 levels (group I (N = 6): 13.4 ± 2.9 ng/ml; group II (N = 6): 23.4 ±
3.0 ng/ml). Otherwise, patients were selected to have similar anthropometric charac-
teristics (Table A-8) to ensure that no other eﬀects, such as BMI (18), were masking
the lipid proﬁle.
The analysis of the lipidomics data showed no signiﬁcant diﬀerences for any of the
monitored lipid classes (Table A-2). In accordance with that, TC and TG were not
altered for both groups. The subsequent analysis of acquired FT MS/MS did not show
any signiﬁcant alteration in the FA composition of the lipid classes. Yet, I detected
quantitative diﬀerences for several lipid species within these classes (Table 3.8). This
species belonged mainly to DAG and TAG. They had fatty acid moieties with less than
18 carbon and less than 3 double bounds. Their level was always twice as high in group
II, at elevated FABP4 level. PE 36:3 showed the same change.
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Table 3.8: Lipidomics changes upon altered FABP4 level in humans. – Data are
represented by the average and SD for each group.
Lipid specie Concentration,  M Change, % p-value
Group I Group II
PE 36:0 1.2 ± 0.6 0.5 ± 0.3 -55 0.05
PE 36:3 0.3 ± 0.3 1.0 ± 0.7 267 0.04
PC 36:3 121.2 ± 15.9 150.8 ± 26.1 24 0.04
DAG 32:1 3.3 ± 2.3 11.2 ± 6.3 241 0.03
DAG 34:1 33.1 ± 8.0 57.1 ± 14.0 72 0.01
DAG 34:2 15.6 ± 7.4 28.4 ± 4.9 83 0.01
DAG 36:1 7.0 ± 4.0 16.6 ± 5.9 138 0.01
TAG 44:0 1.9 ± 2.4 7.6 ± 5.0 293 0.04
TAG 46:0 4.2 ± 3.4 15.4 ± 9.8 265 0.04
TAG 46:1 8.5 ± 5.3 23.9 ± 13.6 179 0.04
TAG 46:2 3.1 ± 2.3 10.6 ± 6.5 241 0.04
TAG 46:3 0.5 ± 0.8 2.5 ± 1.9 372 0.05
TAG 48:0 8.4 ± 3.5 28.3 ± 18.9 236 0.05
TAG 48:2 19.0 ± 5.1 43.6 ± 23.0 129 0.05
TAG 48:3 5.7 ± 2.1 12.2 ± 5.3 116 0.03
3.5.3.2 Discussion
Lipidomics of blood plasma samples from healthy individuals with similar BMI revealed
changes in the DAG and TAG proﬁle but not in the total amount of the lipid class. The
corresponding species had FA moieties with less than 18 carbons and less than 3 double
bonds. Their level was more than 2 times increased when the FABP4 was elevated in
the blood plasma. Yet, a speciﬁc increase of FA 16:1 (z9) was not detectable within
the analyzed lipid classes.
One disadvantage of the chosen lipidomics approach is that FFAs are not quantiﬁed.
Thus, the distribution in the FFA could not be judged as it was done for previous studies
linking FABP4 and glucose homeostasis.
Further insight into alteration of the lipid metabolism upon changed FABP4 ex-
pression might be achieved by fractionation of blood plasma, which would oﬀer a more
precise read-out for the lipid metabolism.
Apart from analytical limitations, this study lacked the supply with blood plasma
samples of suﬃcient quality and from well deﬁned patients. Hence, more than 15 %
of the entirety of measured samples (N = 91) the blood plasma was lipaemic with
correspondingly elevated TAG levels of 4.11 ± 1.23 mM. Also, the variability of the
anthropometric data (e.g. age: 19 to 80 y) was too big for solid conclusions.
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3.5.4 Quality control of pancreatic islets
Between organ procurement and transplantation there are miscellaneous factors neg-
atively aﬀecting the functionality of islets. A quality control of isolated human islets
prior to transplantation is therefore important to assure a positive clinical outcome.
However, we currently lack sensitive tests that allow to characterize the quality and
evaluate the functionality of islets prior transplantation into T1D patients. One op-
portunity is given by absolute quantitative characterization of lipid metabolites. Thus,
previous studies investigating the phenomena of apoptosis, inﬂammation and stress
response, observed several alterations of the lipidome (38, 74). This project aims at
evaluating the sensitivity of lipidomics in terms of assessing quality and functionality of
islet preparations. The achieved lipidomics data were correlated with the islet function
in vivo.
3.5.4.1 Alteration of the islet lipidome due to outer inﬂuences
Lipid analysis consumed less the 1.000 islet equivalents, which were washed by 150
mM ammonium acetate solution prior to extraction by MTBE recipe in the presence of
internal standards. A minimum measuring time was ensured by FT MS only acquisi-
tions. The shotgun lipidomic analysis revealed that stress response of isolated rat islets
is accompanied by increased levels of Cer, decreased levels of DAG, and concurrently by
the increased abundance of PS (Figure 3.37). The alterations of the lipidome correlated
with islet viability and function in vivo.
Control islets, that were directly frozen after preparation, had a Cer level of 1.8
± 0.3 mol%. The content of DAG and PS was determined to be 5.7 ± 0.4 mol% and
8.4 ± 0.2 mol%, respectively. Upon inhibition of the respiratory chain by Rotenone an
increase of Cer to 3.0 ± 0.3 mol% and of PS to 11.0 ± 0.7 mol% was detected. DAG was
slightly reduced to 4.7 ± 0.3 mol%. In vivo Rotenone treated integrated islets were not
able to normalize the blood glucose level in mice (Figure 3.38; approximately 20 mM
glucose instead of less than 8 mM). Similar cytokine treatment resulted in reduction of
Cer (2.6 ± 0.4 mol%) and DAG (2.5 ± 0.2 mol%) contents. The PS content of these
islets was not signiﬁcantly altered.
Further, islets were subjected to cold ischemia conditions. 6 h storage under these
conditions started to alter the lipid composition whereas only DAG was signiﬁcantly
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Figure 3.37: Alteration of the rat islet lipidome in response to in vitro con-
ditions. – Rat islet were isolated an exposed to diﬀerent condition in vitro. Lipidomics
alterations observed by subsequent shotgun analysis revealed changes in Cer (A), DAG (B)
and PS (C) content.
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altered to 4.9 ± 0.4 mol%. Under in vivo conditions, these islets possess decreased
capacity to normalized blood glucose level compared to control (Figure 3.38). Storage
of islets for about 20 h led to strong changes of their lipid composition (Cer: 3.5 ± 0.3
mol%; DAG: 1.7 ± 0.3 mol%; PS: 12.2 ± 1.3 mol%). The alterations are similar to
Rotenone and cytokine treatment indicating their loss of function.
The analysis of individual subjects within the control group, indicated subtle func-
tional diﬀerences that are so far only evident after glucose challenge (ipGTT) 10 d after
transplantation, and were further found to be reﬂected in the speciﬁc lipid proﬁle.
Lipidomic data obtained for human islets preparation showed a large distribution in
the appearance of lipid species between diﬀerent preparations. Results were correlated
with donor and isolation characteristics and QC tests. Lipid data thereby seems to
anticipate in vivo function measured as metabolic restoration of diabetic mice after
transplantation.
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Figure 3.38: In vivo functional assessment of islet transplantation. – Islet trans-
plantation of 300 islet equivalents beneath the kidney capsule of streptozotocin-induced
diabetic NOD-SCID mice. After transplantation, mice with control and 6 h stored islets
had stable normoglycemia (blood glucose of 8.1 ± 1.0 mM and 5.2 ± 0.5 mM). Hyper-
glycemia was observe to Rotenone treated islets (blood glucose of 18.3 ± 2.5 mM). Data
borrowed from Dr. B. Ludwig.
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3.5.4.2 Discussion
We observed that the exposure of islets to hypoxia, oxidative or inﬂammatory stress
induces alterations of the lipidome, especially DAG, Cer and PS. These changes were
found to correlate well with the viability and function of the islets. The lipid proﬁles
seemed to reveal even small diﬀerences in functionality in vivo that were otherwise
not detectable. Therefore, shotgun lipidomics may help to optimize workﬂow and to
control the quality and functionality of islet preparations.
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3.5.5 Identiﬁcation of unknown lipids: the maradolipids
Living beings need to be adaptable to environmental factors in order to survive. As a
consequence of harsh conditions, e.g. the nematode C. elegans interrupts its life cycle
and transitions into a Dauer state. In this process, the morphology and the metabolism
are adjusted to increase the stress resistance and the probability of surviving. Changes
of the metabolism were investigated by comparative lipidomics of larvae and Dauer
states of the temperature-sensitive C. elegans mutant daf-2 (e1370).
3.5.5.1 Characterization of maradolipids by high resolution mass spec-
trometry
Prior to mass spectrometric analysis, the lipids were extracted from daf-2 (e1370)
states according to Bligh and Dyer (75) and separated by two dimensional thin layer
chromatography (2D TLC). Lipids with carbohydrate moieties were ascertained using
the Molisch’s test. By this a qualitative diﬀerence in the composition of the lipidome
of daf-2 (e1370) Dauers could be detected.
The analytes in question were isolated and analyzed by DDA of HCD FT MS/MS
on a LTQ Orbitrap XL. The maradolipids (Mar) were detectable as acetate adducts
([M + CH3COO]
−). Lipid species were isolated by the LTQ and fragmented by HCD
as described above (Section 3.2). Resulting FA moieties and the complementary tre-
halose residue were detected in the Orbitrap mass analyzer (Figure 3.39). The analysis
revealed a high heterogeneity of the Mar lipids (Figure 3.40).
Independent LC/MS measurements of the hydrolyzed Mar FA identiﬁed FA mo-
ieties with C15 and C17 as monomethyl branched-chain FA (mmBCFA) (76, 77) that
represented about 40 mol% of all FA. Correspondingly, approximately 66 % of Mar,
identiﬁed by DDA of HCD FT MS/MS, contain at least one mmBCFA moiety.
90
3.5 Biological and medical applications
200 220 240 260 280 300 320 340m/z
0
10
20
30
40
50
60
70
80
90
100
0
10
20
30
40
50
60
70
80
90
100
R
el
. a
bu
nd
an
ce
, %
600
m/z
500400300200 700 800 900 1000
[FA - H]-
[M1 - FA 18:1 - H]
-
547.3116 [M1 - FA 15:0 - H]
-
587.3428 [M1 - H]
-
829.5666
[M1 - CH3COO]
-
889.5879
[M2 - H2O - H]
-
323.0980
[M2 - 2H2O - H]
-
305.0875
[FA 15:0 - H]-
241.2171
[FA 14:0 - H]-
227.2015
[FA 16:0 - H]-
255.2328
[FA 17:1 - H]-
267.2327
[FA 18:1 - H]-
281.2484
[FA 19:1 - H]-
295.2640
A
B
O
O
OHOH
OH
O
O
OH OH
OH
O
O
O
Figure 3.39: Structure formula and fragment spectra of 6-O-(13-
methylmyristoyl)-6-O-oleoyltrehalose. – (A) The structure formula of maradolipid
Mar 15:0/18:1 ([M + CH3COO]
−). (B) HCD FT MS/MS spectrum of Mar 33:1 ([M +
CH3COO]
−, m/z 889.5881) revealed that the precursor detected in FT MS represents a
mixture of several isobaric species comprising a trehalose backbone and two diﬀerent FA.
The HCD FT MS/MS spectrum was acquired at nCE of 35 %. Peaks corresponding to
FA are annotated by m/z, the number of carbon atoms and double bonds. The trehalose
backbone was detected at m/z 323.0980 and 305.0875. Mar 33:1 represented a mixture of
Mar 15:0/18:1, Mar 16:1/17:0, Mar 16:0/17:1, and Mar 14:0/19:1.
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Figure 3.40: Composition of maradolipids isolated from C. elegans Dauers. –
(A) Precursor ions of Mar ([M + CH3COO]
−) were analyzed by HCD FT MS/MS at nCE
of 35 % on XL. The abundance of a lipid species is determined by the sum intensity of
complement FA. Relative abundance of the species was determined by normalization to the
sum of all species. (B) FA composition of maradolipids as determined by DDA of HCD
FT MS/MS. Blue bars: mmBCFA; green bars: straight-chain FA; red bars: cyclopropyl
FA. The bar diagram represents the relative abundance and SD of 3 experiments.
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3.5 Biological and medical applications
3.5.5.2 Discussion
The shotgun lipidomics analysis of isolated Mar lipids from C. elegans daf-2 (e1370)
Dauer enabled their conﬁrmation and the speciﬁcation of their molecular composition.
Although their biological function is yet not proven, it might be presumed that they
function as glucose and fat reservoir in analogy to glycosylated DAG in seeds of ce-
reals (78, 79). Furthermore, homologue synthetic trehalose-based diester have been
previously described to form gels (80).
The achieved result demonstrated the capability of the established shotgun lipidomics
approach not only to screen for known lipids but also to identify new, so far unknown
lipids. Crucial was therefore the ability to perform high resolution HCD FT MS/MS
measurements for speciﬁcity and the ability to analyze the obtained data provided by
the LipidXplorer software.
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4Conclusions
Within the thesis several methodical issues of the shotgun lipidomics analysis were
successfully addressed:
1. In consideration of studies with large sample scale, as common in medical research,
I attempted to simplify the workﬂow of lipidomics screens. Therefore, I performed
lipidomics measurements on the high resolution LTQ Orbitrap instrument with
successively altered polarity in order to consider lipid class dependent ionization
properties. Mass accuracy in dual-polarity acquisitions was maintained by online
calibration using chemical background ions. By this, I could increase the accuracy
of absolute quantiﬁcation of major blood plasma lipid classes compared to FT
MS(+) only measurements. The dual-polarity acquisition method enabled the
determination of the lipid composition of a blood plasma sample within 7 minutes.
Apart from the additional information gain, the method signiﬁcantly reduced
material costs and eﬀort of lipidomics screens.
2. In order to perform bottom-up lipidomics experiments on LTQ Orbitrap instru-
ments the technical characteristics had to be speciﬁed. Here, I demonstrated that
HCD outperforms linear ion trap CID and PQD fragmentation. Via HCD, ions of
small m/z as low as 100 could be assessed without compromising sensitivity. The
degree of fragmentation of lipid precursors was assessable by CE. Finally, mole-
cular lipid species could be analyzed by HCD FT MS/MS reaching four orders of
magnitude dynamic range.
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Mass resolution and accuracy of the Orbitrap increased the speciﬁcity of FT MS
and FT MS/MS measurements. This allowed the characterization of unusual
VLC PUFA containing PC species in rat retina and helped to identify a new
lipid class in nematode C. elegans, the maradolipids. Yet, mass resolution is not
suﬃcient to prevent occurrent ambiguities of the fragment assignment.
To enable straight bottom-up lipidomics, the data analysis needs to be optimized.
High resolution DDA data are currently only analyzable by the LipidXplorer
software if their volume is limited. Furthermore, additional data mining software
could simplify the handling of large experimental data sets.
3. For the ﬁrst time, the fragmentation of GPL species, varying in their degree of
saturation, was systematically analyzed in a relative quantitative manner. Since
being commercially not available, I had to synthesize a series of GPL species con-
taining the main mammalian FA. Their analysis by HCD FT MS/MS uncovered
discrete fragmentation properties of the FA carboxylate ions that eﬀects the re-
covery from GPL species. Essential inﬂuencing variables on the carboxylate ion
recovery were (I) the number of double bounds, (II) their position relative to the
carboxyl group, and (III) the alkyl chain length.
Here it has to be states, that we need to develop a theoretical model by which
correction factors for accurate absolute quantiﬁcation of molecular lipid species
can be calculated.
The reﬁned lipidomics methods were used to answer questions related to the lipid
metabolism:
1. In order to enable shotgun lipidomics analysis of lipoproteins, a fractionation
method was adapted being compatible to the established shotgun lipidomics rou-
tines. This allowed the detailed analysis of the lipoprotein composition and to
study their inﬂuence, e.g. by apheresis.
The detected lipidomics changes in blood plasma caused by apheresis were in
agreement with the manufacturers’ data. Yet, since total plasma samples were
analyzed, the removal and the recovery of speciﬁc lipoproteins like vLDL, LDL
and HDL was not directly attested by our measurements. To understand the lipid
ﬂux in man, this will be needed.
96
2. We discovered lipidomics changes associated with diabetes risk. Patients with
IGT and T2D exhibited signiﬁcant decreased circulating CholE and PC-O com-
pared to control individuals. The analytes correlated with HOMA, GSI, and ISI.
Negative correlation of obesity measures and positive association of total CholE
with the insulin and glucose sensitivity marker ISI and GSI indicate their poten-
tial beneﬁcial role for the glucose homeostasis.
The circulating levels of PC-O in T2D patients were diminished compared to
control patients. Their detailed correlation analyses further revealed a pattern of
individual PC-O species with shorter (C32 to C36) FA moieties with 0 to 3 double
bonds, which were associated with higher insulin sensitivity as estimated by ISI.
3. The assessment of the graft quality in terms of functionality and viability prior
transplantation could help to improve the transplantations success. Here, we
tempt to assess the quality of pancreatic islets by lipidomics evaluation using the
established shotgun lipidomics approach. We observed that the exposure of islets
to hypoxia, oxidative or inﬂammatory stress induces alterations of the lipidome,
whereas especially the levels of DAG, Cer and PS were altered. The changes
correlated with the viability and function of the islets. The lipid proﬁles thereby
seemed to reveal even small diﬀerences in functionality in vivo that were otherwise
not detectable.
97
4. CONCLUSIONS
98
5Materials and methods
5.1 Chemicals and lipid standards
Synthetic lipid standards and a total lipid extract of bovine heart were purchased
from Avanti Polar Lipids, Inc. (Alabaster, AL) or Sigma-Aldrich Chemie (Munich,
Germany); common chemicals and solvents of ACS or LC-MS grade from Sigma-Aldrich
Chemie (Munich, Germany) or Fluka (Buchs SG, Switzerland);methanol (LiChrosolv
grade) from Merck (Darmstadt, Germany).
5.2 Annotation of lipids
Individual molecular species of GLs and GPLs were annotated as follows: 〈lipid class〉
〈no. of carbon atoms in sn-1 FA or FA-O moiety〉:〈no. of double bonds in sn-1 FA or
FA-O moiety〉/〈no. of carbon atoms in sn-2 FA moiety〉:〈no. of double bonds in sn-2
FA moiety〉. For example, PC 18:0/18:1 stands for a phosphatidylcholine comprising
the moieties of stearic (FA 18:0) and oleic (FA 18:1) FAs. If the exact composition
of FA or FA-O moieties was undetermined, the species were annotated as 〈lipid class〉
〈no. of carbon atoms in both moieties〉:〈no. of double bonds in both moieties〉. In this
way, PC 36:1 stands for the PC species having 36 carbon atoms and one double bond
in both FA moieties. TAG and CL species were analog labeled.
Molecular species of SL were annotated as follows: 〈lipid class〉 〈no. of carbon atoms
in LCB〉:〈no. of double bonds in LCB〉/〈no. of carbon atoms in the FA moiety〉:〈no.
of double bonds in the FA moiety〉. For example, Cer d18:1/16:0 stands for a ceramide
comprising sphingosine LCB and palmitic FA (FA 16:0). If the exact composition was
99
5. MATERIALS AND METHODS
unspeciﬁed, as in FT MS only measurements, the species were annotated as 〈lipid class〉
〈no. of carbon atoms of LCB and FA moiety〉:〈no. of double bonds in both〉:〈no. of
hydroxyl groups〉. In this way, Cer 34:1:2 stands for a Cer species having 34 carbon
atoms, one double bond in the alkyl chains and two hydroxyl groups.
5.3 Lipid extraction by methyl-tert butyl ether/methanol
Total lipid extracts from homogeneous or homogenated samples were prepared as pre-
viously described with minor modiﬁcations (56). Brieﬂy, in a 1.5 ml Eppendorf tube
(Eppendorf, Hamburg, Germany) a aliquot of the lipid containing sample (e.g. 5  l of
blood plasma) was mixed with 700  l of a methyl-tert-butyl ether (MTBE)/methanol
mixture (v:v – 10:3) spiked with one synthetic standards of per lipid class in a project
speciﬁc concentration. The mixture was incubated at 4  for 1 h on a shaking platform.
To initiate phase separation, 135 l of water were added. Shaking was then continued
for 15 min. Phase separation was completed upon centrifuging for 5 min in a benchtop
centrifuge MiniSpin (Eppendorf, Hamburg) at 13.400 rpm. The upper organic phase
was collected and stored at −25   under nitrogen.
5.4 General procedure of shotgun lipidomics mass spec-
trometric analysis
Total lipid extracts or lipid standards were diluted with a mixture of isopropanol/-
methanol/chloroform (v:v:v – 4:2:1) containing 7.5 mM ammonium formate or ammo-
nium acetate (speciﬁc for each experiment). Also, where speciﬁed, I used a mixture
of methanol/chloroform 5:1 (v:v) containing 0.1 % (v:v) triethylamine. Prior to the
analysis, samples were loaded into a 96-well plate (Eppendorf, Hamburg, Germany),
sealed with aluminum foil, and centrifuged for 5 min at 4.000 rpm on a Multifuge
3S-R centrifuge from Heraeus DJB Labcare Ltd. (Newport Pagnell, U.K.). Dilution
of the total lipid extracts and the synthetic standards were selected individually for
each experiment. Mass spectrometric analyses were performed on the XL, Velos and
QExactive instruments (ThermoFisher Scientiﬁc, Bremen). Instruments were equipped
with the robotic nanoﬂow ion source TriVersa (Advion BioSciences, Ithaca, NY) us-
ing chips with spraying nozzles with a diameter of 4.1 m and controlled by Chipsoft
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XL
6.4 software. The ionization voltage and gas back pressure were set to 1.25 kV and
0.95 psi in the positive and −0.7 kV and 1.06 psi in negative ion modes, respectively.
Under these settings, 10  l of the analyte was electrosprayed for more than 50 min.
The temperatures of the ion transfer capillary were 125 and 200   for the XL and Ve-
los/QExactive, respectively; the tube voltages were 90 V (MS(+)) or 150 V (MS(−))
on XL; and the s-lens level was 58 % / 50 % for Velos/QExactive.
5.5 Impact of polarity switching on the instrument mass
accuracy of the XL
A polar bovine heart extract (2.5 g/mL in isopropanol/methanol/chloroform 4:2:1
(v:v:v) containing 7.5 mM ammonium formate) was treated as above mentioned (sec-
tion 5.4). For this experiment: (I) 5 FT MS(+) acquisitions were performed without
engaging the lock mass option under stable instrument conditions; (II) 5 FT MS(+)
acquisitions were performed with engaged lock mass option under stable instrument
conditions; (III) 5 FT MS acquisitions for each positive and negative mode were per-
formed without engaging the lock mass option after polarity switch; (IV) 5 FT MS
acquisitions for each positive and negative mode were performed with engaged lock
mass option after polarity switch. The acquisitions were performed on LTQ Orbitrap
XL under mentioned setting (Section 5.4). The samples were sprayed for 45 min. FT
MS mass resolution R m/z 400 was 130.000 (FWHM); target value for AGC was 5 ×
105 and maximum injection time was 250 ms. One FT MS scan was acquired within
3.52 s. The total acquisition time for all FT MS spectra was 45 min. From each scan
intensity and precursor mass for PC-O 34:3 ([M + H]+, calc. m/z 742.574516; [M +
HCOO]−, calc. m/z 786.565443) were extracted.
5.6 Selection and characterization of reference background
peaks
FT MS spectra were acquired from ﬁve diﬀerent lipid extracts and one blank at the
target mass resolution of R m/z 400 of 130.000 (FWHM). Spectra were imported by
LipidXplorer software into a MasterScan database under the following settings: range
of m/z 365 to 1200; minimal peak intensity cut-oﬀ Imin of 1 × 105; mass tolerance 5
101
5. MATERIALS AND METHODS
ppm. Occupation threshold (the frequency at which peaks should occur in the spectra
at the intensity above Imin) was set to 1.0. Eﬀectively, this implied that peak candidates
were detected in each sample and in the blank with the intensities exceeding Imin/
√
n,
where n is the number of acquired scans, and their m/z were not aﬀected by overlapping
peaks.
MSn of background peaks was performed by CID at the XL. Precursor ions were
isolated within the width of 1.8 Th and, upon CID, fragment ions were detected at the
linear ion trap at the unit mass resolution or at the Orbitrap at R m/z 400 of 130.000
(FWHM). Spectra were acquired under operator control and nCE was optimized for
each analyte individually by automated ramping.
5.7 Dual-polarity acquisition of high resolution FT MS
spectra from total lipid extracts
Lipid extracts were treated as above described (Section 5.4). Dual-polarity acquisi-
tion, direct infusion experiments were performed on the LTQ Orbitrap XL instruments
(ThermoFisher Scientiﬁc, Bremen), equipped with a modiﬁed robotic nanoﬂow ion
source TriVersa (Advion BioSciences, Ithaca, NY). The ionization voltage and gas
back pressure were set to 1.25 kV and 0.95 psi in the positive and negative ion mode,
respectively. The XCalibur MS method ﬁle consisted of two segments, one for negative
and one for positive FT MS acquisitions. Both acquisitions used the same LTQ tune
ﬁle with setting as above described (Section 5.4). The contact closure was set to ’open’
status in the ﬁrst segment and to ’close’ status in the second. Start of FT MS acqui-
sition by the Orbitrap instrument was initiated by contact closure signal from the ion
source. Sample infusion and FT MS acquisition were temporally synchronized. In the
ﬁrst segment FT MS(−) spectra were acquired by electrospraying the sample at −1.25
kV for 3.49 min. Then the contact closure signal of the LTQ Orbitrap XL changed the
spraying voltage of the ion source to +1.25 kV. Subsequently, FT MS(+) spectra were
acquired for 3.5 min. The sample infusion and the acquisition cycle was ended at 7.05
min in shotgun experiments.
Mass accuracy in dual-polarity experiments was maintained by online calibration us-
ing lock mass function. Reference peaks were octadecyl(ditertbutyl-hydroxyphenyl)pro-
pionate ([M−H]−, m/z 529.46262) and tris(ditert-butylphenyl) phosphate ([M + H]+,
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m/z 647.45876); tris(ditert-butylphenyl) phosphate ([M + H]+, m/z 663.45367 and [M
+ NH4]
+, m/z 680.48022).
5.8 Investigation of the precursor isolation properties of
XL and Velos
The accuracy of precursor isolation was monitored by the method of total ion map-
ping. To this end, MS/MS spectra were acquired with the ion trap or (where spec-
iﬁed) with the Orbitrap analyzer, while the target precursor m/z was changed with
step increments of 0.1 Th. Precursor isolation width was set to 1.0 Th; maximum
injection time to 100 ms, AGC to 5.000 (ions), nCE to 1 %. The resolution for FT
MS/MS was set to R m/z 400 of 10.000 (FWHM). The oﬀset values for species of diﬀerent
lipid classes were determined by analyzing a mixture of the synthetic lipid standards
LPC 12:0, PC 12:0/12:0, PC 14:0/14:0, PC 22:0/22:0, PC 24:0/24:0, Cer d18:1/17:0,
CL 14:0/14:0/14:0/14:0, GlcCer d18:1/17:0, PG 17:0/17:0, SM d18:1/17:0, and PC
17:0/17:0, each at a concentration of 0.5  M.
The isolation width dependent ion transmission of the LTQ was studied by and
PE 16:0/226 and PC 16:0/22:6 in negative mode. Standards were treated as above
mentioned (Section 5.4). The isolation oﬀset was considered when the isolation width
was increased from 1.0 to 2.0 Th. The resolution for FT MS/MS was set to R m/z 400
of 10.000 (FWHM).
5.9 Comparison of CID, PQD and HCD fragmentation
Lipid standard PE 18:1/18:2 was treated and analyzed on a LTQ Orbitrap Velos as
above described (Section 5.4). The fragmentation of the precursor ion in negative mode
([M − H]−) via CID, PQD, and HCD was monitored FT MS/MS while ramping nCE.
MS/MS settings: isolation width of 1.5 Th; IT max of 100 ms; AGC value was 25.000;
R m/z 400 of 40.000 (FWHM). 3 FT MS/MS scans were averaged to one spectra.
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5.10 Determination of the dynamic range for HCD FT
MS/MS on the Velos
Serial dilutions of a synthetic lipid standard mixture comprising PC 17:0/17:0, PE
17:0/17:0, PI 16:0/16:0, PS 12:0/12:0, PG 17:0/17:0 and CL 14:0/14:0/14:0/14:0 were
analyzed within a concentration range of to 0.1 nM to 10  M. As reference, SM
d18:1/17:0 was kept at 0.5  M. Measurement were performed on LTQ Orbitrap Ve-
los as described above. Diﬀerently, AGC target was set to 5 × 104. Isolation width
was 1.5 Th, no oﬀset for precursor selection was applied and nCE was set to 70 %.
5.11 Data dependent acquisition of HCD FTMS/MS from
total lipid extracts
Data-dependent experiments were constructed as previously described (34). Corre-
spondingly, each DDA cycle consisted of one FT MS survey spectrum acquired at the
target resolution R m/z 400 of 130.000, followed by the acquisition of ﬁve HCD FT
MS/MS spectra at the resolution R m/z 400 of 40.000. The prescan option was dis-
abled such that accurate masses could be recognized. Precursor ions were subjected to
MS/MS if their m/z matched the masses in the inclusion list with the accuracy of < 5
ppm. In MS/MS experiments, precursor ions were isolated at the linear ion trap with
the isolation width of 1.6 Th, and the ITmax was set to 4 s, each spectra consisted of
2 MS/MS scans. Exclusion time was set to 20 min. On average, a DDA experiment
was completed in 40 min such that each precursor was 4 times fragmented. In HCD
mode, nCE was set to 45 %. Fragments (m/z smaller than 100) were detected by the
Orbitrap analyzer at the resolution R m/z 400 of 40.000 (FWHM). The measurement
time for acquiring one HCD FT MS/MS spectrum was 5.4 s. The lock mass option was
enabled. The abundant background anion of octadecyl-(di-tert-butyl-hydroxyphenyl)
propionate ([M − H]−) with m/z 529.46262 was used as a reference peak. Target AGC
values were set to 1 × 106 and 2.5 × 104 for FT MS and FT MS/MS modes, respec-
tively. In FT MS, ITmax was 100 ms and 3 scans were averaged for each spectrum.
DDA experiments were repeated four times for each sample and twice for the blank.
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5.12 Analysis of lipidomics data sets
Lipids could be identiﬁed from high resolution FT MS and FT MS/MS by LipidXplorer
software (36). Queries were compiled for all described lipid classes.
5.13 Synthesis of PC and PC-O species by esteriﬁcation
1.5  mol of FFA in CHCl3 were added into 7 ml glass vial. The FFA was the dried
under vacuum for 3 h. 250  l of acetyl chloride were added under nitrogen. The
closed vial was incubated for 60 min at 85  . Excess acetyl chloride was the removed
under vacuum for 2 h. 1.5 mol LPC 16:0 or LPC-O 16:0 suspended in dry CHCl3 were
added. The mixture was then incubated under nitrogen at 30  for 15 min, dried under
vacuum, dissolved in CHCl3 and store under nitrogen and at −25  . The synthesized
standards were characterized by high resolution HCD FT MS/MS on LTQ Orbitrap
Velos.
5.14 Breakdown analysis of synthesized PC and PC-O
species by HCD FT MS/MS
The breakdown of the lipid analytes was measured on a LTQ Orbitrap Velos equipped
with a standard ESI source. Sample infusion was realized via syringe pump. Flow rate
was set to 5 l/min. The spray voltage was −3 kV; no sheath gas was applied. All other
instrument parameter were conserved (Section 5.4). Precursor of interest was isolated
for HCD FT MS/MS with an oﬀset of −0.15 Th as speciﬁed before. nCE was ramped
from 0 to 120 % while HCD FT MS/MS were recorded. The breakdown spectra were
saved in a separate raw ﬁle for each analyte.
5.15 Preparation of lipoproteins using D2O
For lipoprotein fractionation I adapted the protocol of Hallberg et al. (69) as followed.
Three solution of (I) H2O, (II) D2O (both with 150 mM ammonium formate) and (III)
D2O saturated with ammonium formate were prepared. Solution (I) and (II) were
mixed (v:v – 20:1) to give solution (A) (ρ = 1.006 g/ml, at 20  ); (III) was diluted
with D2O to give solution (B) (ρ = 1.112 g/ml, at 20  ). Then, 0.5 ml of plasma
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were mixed with 0.5 ml solution (A). The mixture was centrifuged at 20   for 100
min at 100.000 rpm. VLDL was collected by aspiration of 0.45 ml from the top of the
tube. Then 0.5 ml of solution (B). The mixture was centrifuged at 20   for 100 min
at 120.000 rpm. LDL was collected by aspiration of 0.45 ml from the top of the tube.
HDL and plasma proteins were recovered from the bottom of the tube.
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6Appendix
Table A-1: Composition of standard mixture for lipid quantiﬁcation in human
blood plasma by FT MS. – The concentration of lipid standards (impurities < 1 %) is
speciﬁed for aliquotes of the extraction mixture (V = 700  l MTBE/MeOH (v:v – 10:3)).
Standard Concentration,  M
CholE 12:0 7.8
CholD7 7.1
TAG 12:0/12:0/12:0 4.9
DAG 12:0/12:0 0.6
Cer 30:1:2 0.5
PC-O/-O 18:0/18:0 5.4
PE-O/-O 20:0/20:0 7.8
PS 12:0/12:0 0.6
PI 16:0/16:0 0.3
SM 30:1:1 1.2
Table A-2: Average concentration of lipids in human blood plasma of 10 indi-
viduals. – Each total extract was analyzed twice by successive acquisition of FT MS(+)
and FT MS(−) spectra. Values represent the average or SD of 20 independent experiments.
Lipid m/z* Mass accuracy, ppm Average Standard
species positive negative positive negative concentration, deviation,
 M  M
[M+NH4]
+
Chol 404.3886 -0.23 1334.80 284.99
[M + NH4]
+
CholE 14:0 614.5871 0.08 30.76 12.34
CholE 15:0 628.6029 0.29 7.89 2.83
CholE 16:0 642.6186 0.41 421.98 104.35
CholE 16:1 640.6030 0.45 182.87 88.99
continued on next page
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Table A-2 – continued from previous page
Lipid m/z* Mass accuracy, ppm Average Standard
species positive negative positive negative concentration, deviation,
 M  M
CholE 17:0 656.6354 2.12 6.74 3.02
CholE 17:1 654.6186 0.35 12.43 3.99
CholE 18:0 670.6490 -0.98 19.22 8.05
CholE 18:1 668.6336 -0.60 929.52 227.71
CholE 18:2 666.6183 -0.03 3086.02 693.79
CholE 18:3 664.6028 0.11 122.10 34.13
CholE 19:2 680.6329 -1.59 10.52 6.95
CholE 20:2 694.6490 -0.89 3.57 1.66
CholE 20:3 692.6336 -0.53 54.82 18.06
CholE 20:4 690.6182 -0.23 547.73 191.99
CholE 20:5 688.6025 -0.24 87.14 51.94
CholE 22:5 716.6338 -0.31 2.64 1.45
CholE 22:6 714.6183 -0.01 50.35 25.89
[M + NH4]
+
TAG 44:0 768.7074 -0.18 2.23 2.96
TAG 44:1 766.6923 0.54 2.86 3.53
TAG 46:1 794.7230 -0.24 8.66 7.75
TAG 46:2 792.7073 -0.38 3.49 3.73
TAG 46:3 790.6919 -0.07 0.97 1.04
TAG 47:1 808.7387 -0.23 1.76 1.95
TAG 48:1 822.7543 -0.24 24.69 26.62
TAG 48:2 820.7387 -0.20 18.13 17.17
TAG 48:3 818.7231 -0.19 5.41 4.28
TAG 49:1 836.7700 -0.20 3.32 3.38
TAG 49:2 834.7544 -0.09 2.53 2.03
TAG 49:3 832.7391 0.34 1.37 0.51
TAG 50:1 850.7855 -0.36 54.23 56.61
TAG 50:2 848.7700 875.7348 -0.22 0.25 75.78 64.58
TAG 50:3 846.7544 -0.15 32.90 25.05
TAG 50:4 844.7388 -0.09 7.88 5.29
TAG 50:5 842.7232 -0.04 1.36 0.88
TAG 51:1 864.8011 -0.37 2.33 2.61
TAG 51:2 862.7857 -0.09 5.92 4.73
TAG 51:3 860.7701 -0.05 3.33 2.11
TAG 51:4 858.7545 -0.03 0.91 0.61
TAG 52:2 876.8010 903.7661 -0.54 0.28 158.98 115.36
TAG 52:3 874.7856 901.7504 -0.28 0.18 138.33 83.95
TAG 52:4 872.7700 899.7348 -0.13 0.29 54.12 31.47
TAG 52:5 870.7546 0.09 12.34 7.36
TAG 52:6 868.7387 -0.16 2.41 1.32
TAG 53:2 890.8169 -0.21 2.74 2.02
TAG 53:3 888.8013 -0.20 2.98 1.86
TAG 53:4 886.7858 -0.06 1.14 0.88
TAG 53:5 884.7697 -0.50 0.47 0.37
TAG 54:2 904.8303 -2.69 3.83 4.54
TAG 54:3 902.8169 929.7818 -0.26 0.36 39.94 27.36
TAG 54:4 900.8013 927.7660 -0.22 0.19 35.94 22.67
continued on next page
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Table A-2 – continued from previous page
Lipid m/z* Mass accuracy, ppm Average Standard
species positive negative positive negative concentration, deviation,
 M  M
TAG 54:5 898.7856 -0.20 24.45 14.91
TAG 54:6 896.7700 -0.18 11.72 6.58
TAG 54:7 894.7543 -0.23 3.66 2.17
TAG 54:8 892.7386 -0.34 0.49 0.49
TAG 56:2 932.8630 -1.13 0.64 0.51
TAG 56:3 930.8482 -0.25 1.03 0.89
TAG 56:5 926.8170 -0.12 5.46 3.56
TAG 56:6 924.8013 -0.17 8.68 5.26
TAG 56:7 922.7856 -0.18 9.46 6.60
TAG 56:8 920.7700 -0.17 4.13 3.04
TAG 56:9 918.7543 -0.21 0.72 0.67
TAG 58:5 954.8484 0.03 0.55 0.30
TAG 58:6 952.8327 -0.10 0.68 0.54
TAG 58:7 950.8169 -0.19 1.43 1.08
TAG 58:8 948.8012 -0.25 2.06 2.00
TAG 58:9 946.7855 -0.33 1.34 1.35
TAG 58:10 944.7697 -0.52 1.73 1.61
[M + NH4]
+ [M+HCOO]–
DAG 32:1 584.5249 611.4895 0.11 0.39 1.67 1.56
DAG 32:2 609.4736 0.07 0.72 0.63
DAG 34:1 612.5562 639.5208 0.11 0.45 6.07 5.09
DAG 34:2 610.5405 637.5052 0.08 0.43 3.86 3.40
DAG 34:3 635.4895 0.43 0.85 0.77
DAG 34:4 606.5092 633.4730 0.03 -0.86 1.37 0.71
DAG 36:1 667.5523 0.68 1.02 0.92
DAG 36:2 638.5721 665.5367 0.44 0.73 9.32 5.97
DAG 36:3 636.5564 663.5210 0.38 0.77 6.24 3.83
DAG 36:4 661.5053 0.65 2.21 1.33
DAG 38:5 687.5209 0.55 1.28 0.80
DAG 38:6 685.5055 0.91 0.66 0.59
DAG 40:8 709.5057 1.14 1.31 0.61
[M + H]+ [M+HCOO]–
Cer 34:1:2 582.5105 0.33 0.24 0.07
Cer 36:1:2 610.5418 0.36 0.12 0.05
Cer 38:1:2 638.5732 0.42 0.10 0.06
Cer 40:1:2 666.6047 0.68 0.50 0.15
Cer 41:1:2 680.6202 0.54 0.48 0.20
Cer 42:1:2 650.6449 694.6357 0.53 0.24 1.76 0.53
Cer 42:2:2 648.6292 692.6201 0.45 0.29 1.15 0.38
Cer 43:1:2 708.6514 0.39 0.19 0.10
[M + H]+ [M+HCOO]–
SM 32:1:1 675.5434 719.5349 -0.21 0.56 10.05 3.04
SM 32:2:1 673.5280 717.5196 0.17 1.03 0.59 0.25
SM 33:1:1 689.5587 733.5507 -0.69 0.74 4.65 1.41
SM 34:1:1 703.5748 747.5664 -0.06 0.78 100.96 18.92
SM 34:2:1 701.5592 745.5508 -0.03 0.88 12.73 3.03
SM 35:1:1 717.5905 761.5820 0.05 0.69 1.90 0.52
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Table A-2 – continued from previous page
Lipid m/z* Mass accuracy, ppm Average Standard
species positive negative positive negative concentration, deviation,
 M  M
SM 36:1:1 731.6064 775.5978 0.33 0.92 15.42 4.51
SM 36:2:1 729.5908 773.5821 0.37 0.89 6.72 1.74
SM 36:3:1 727.5750 771.5647 0.27 -1.34 0.31 0.11
SM 37:1:1 745.6219 789.6137 0.17 1.24 0.90 0.45
SM 38:1:1 759.6377 803.6291 0.31 0.92 10.38 3.18
SM 38:2:1 757.6222 801.6139 0.59 1.44 3.88 0.98
SM 39:1:1 773.6532 817.6444 0.09 0.43 3.54 1.30
SM 39:2:1 771.6379 815.6287 0.62 0.34 0.58 0.24
SM 40:1:1 787.6688 831.6598 0.04 0.14 20.88 6.80
SM 40:2:1 785.6523 829.6444 -1.00 0.43 18.77 5.56
SM 40:3:1 783.6378 827.6288 0.42 0.49 1.18 0.46
SM 41:1:1 801.6846 845.6745 0.23 -0.96 4.43 1.78
SM 41:2:1 799.6686 843.6571 -0.16 -3.08 4.85 2.13
SM 41:3:1 797.6535 841.6437 0.46 -0.34 0.77 0.45
SM 42:1:1 815.7000 859.6908 -0.05 -0.19 13.03 4.89
SM 42:1:2 831.6951 875.6862 0.21 0.38 1.29 0.69
SM 42:2:1 813.6845 857.6755 0.16 0.23 58.59 17.76
SM 42:3:1 811.6689 855.6599 0.20 0.27 26.65 8.00
SM 42:4:1 809.6526 853.6443 -0.60 0.37 1.80 0.58
SM 43:1:1 829.7163 873.7060 0.76 -0.67 0.41 0.23
SM 43:2:1 827.7007 871.6913 0.76 0.32 1.93 0.79
[M + H]+ [M−H]–
PE 34:1 716.5239 0.47 1.16 1.28
PE 34:2 714.5083 0.49 2.40 2.67
PE 36:1 744.5555 0.83 0.85 0.75
PE 36:2 742.5398 0.76 5.42 4.64
PE 36:3 740.5241 0.66 1.39 1.56
PE 36:4 738.5085 0.74 3.03 2.76
PE 38:3 768.5549 0.03 0.62 0.40
PE 38:4 766.5398 0.68 6.11 4.06
PE 38:5 764.5241 0.63 1.84 1.46
PE 38:6 762.5084 0.60 4.57 5.16
PE 40:6 790.5402 1.25 2.18 2.11
[M + H]+ [M−H]–
PE-O 34:2 700.5289 0.27 0.62 0.22
PE-O 34:3 698.5133 0.36 1.02 0.45
PE-O 36:2 728.5604 0.64 0.54 0.19
PE-O 36:3 728.5588 726.5447 -0.02 0.57 1.85 0.61
PE-O 36:4 724.5292 0.76 1.64 0.70
PE-O 36:5 722.5134 0.52 3.97 1.31
PE-O 38:4 752.5602 0.30 0.75 0.28
PE-O 38:5 750.5446 0.40 6.01 2.01
PE-O 38:6 750.5436 748.5291 0.54 0.59 5.22 1.70
PE-O 38:7 748.5278 746.5136 0.37 0.79 2.83 1.28
PE-O 40:5 778.5757 0.12 0.34 0.11
PE-O 40:6 776.5599 -0.12 0.70 0.33
PE-O 40:7 774.5448 0.65 1.95 0.81
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Lipid m/z* Mass accuracy, ppm Average Standard
species positive negative positive negative concentration, deviation,
 M  M
PE-O 40:8 772.5293 0.81 1.03 0.60
PE-O 42:6 804.5898 -1.82 0.77 0.38
PE-O 42:7 802.5762 0.71 1.31 0.63
[M + H]+ [M−H]–
LPE 16:0 452.2784 0.40 1.99 0.75
LPE 18:0 480.3097 0.37 3.82 1.07
LPE 18:1 478.2941 0.34 1.65 0.54
LPE 18:2 476.2785 0.42 3.56 1.21
LPE 20:2 504.3098 0.50 0.36 0.16
LPE 20:4 500.2786 0.66 2.83 1.03
LPE 22:6 524.2787 0.79 1.94 0.76
[M + H]+ [M+HCOO]–
PC 30:0 706.5381 750.5293 0.02 0.39 3.68 2.39
PC 32:0 734.5697 778.5609 0.30 0.69 12.73 4.79
PC 32:1 732.5540 776.5453 0.31 0.78 21.63 14.68
PC 32:2 730.5382 774.5298 0.03 0.91 4.31 2.63
PC 33:1 790.5614 1.26 3.93 1.32
PC 33:2 788.5457 1.22 1.07 0.54
PC 34:1 760.5849 804.5760 -0.28 0.02 291.32 95.86
PC 34:2 758.5696 802.5613 0.24 1.16 556.27 187.56
PC 34:3 756.5541 800.5458 0.49 1.42 17.06 7.81
PC 34:4 754.5386 798.5302 0.62 1.45 1.33 0.89
PC 35:1 818.5919 0.31 4.27 1.09
PC 35:2 816.5763 0.33 10.09 2.79
PC 35:3 814.5607 0.41 0.41 0.21
PC 36:1 788.6158 832.6061 -0.69 -1.43 50.29 16.57
PC 36:2 786.6006 830.5918 -0.15 0.17 298.67 56.43
PC 36:3 784.5849 828.5761 -0.22 0.14 174.87 44.12
PC 36:4 782.5693 826.5608 -0.20 0.57 262.59 102.33
PC 36:5 824.5453 0.66 30.90 16.39
PC 37:2 844.6072 -0.10 0.99 0.41
PC 37:3 842.5917 0.07 2.13 0.73
PC 37:4 840.5763 0.31 4.65 2.60
PC 38:3 812.6163 856.6073 -0.12 -0.02 47.44 14.57
PC 38:4 810.6007 854.5923 0.02 0.79 149.76 60.81
PC 38:5 808.5847 852.5761 -0.51 0.08 67.61 22.36
PC 38:6 806.5694 850.5602 -0.01 -0.16 36.45 21.83
PC 38:7 848.5454 0.83 1.62 0.75
PC 39:6 864.5774 1.65 1.04 1.12
PC 40:4 882.6234 0.49 2.59 0.86
PC 40:5 836.6159 880.6072 -0.58 -0.13 9.61 3.16
PC 40:6 834.6005 878.5918 -0.31 0.12 33.50 18.86
PC 40:7 876.5762 0.16 5.88 3.20
[M + H]+ [M+HCOO]–
PC-O 32:0 720.5903 764.5816 0.15 0.65 1.46 0.57
PC-O 32:1 718.5747 762.5660 0.19 0.71 1.55 0.68
PC-O 34:1 746.6062 790.5977 0.52 1.20 3.77 1.00
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Lipid m/z* Mass accuracy, ppm Average Standard
species positive negative positive negative concentration, deviation,
 M  M
PC-O 34:2 744.5905 788.5820 0.48 1.16 6.20 1.73
PC-O 34:3 742.5745 786.5663 0.04 1.14 5.42 1.43
PC-O 36:2 772.6215 816.6126 0.04 0.31 1.71 0.68
PC-O 36:3 770.6058 814.5969 -0.07 0.17 4.42 1.04
PC-O 36:4 768.5903 812.5814 0.11 0.34 12.96 2.99
PC-O 36:5 766.5746 810.5658 0.07 0.39 7.91 2.03
PC-O 38:4 796.6215 840.6125 0.00 0.10 6.64 1.70
PC-O 38:5 794.6059 838.5969 0.09 0.24 14.20 3.97
PC-O 38:6 792.5904 836.5813 0.29 0.20 5.13 1.66
PC-O 38:7 790.5740 834.5661 -0.70 0.74 1.13 0.60
PC-O 40:7 818.6061 862.5975 0.34 0.87 1.75 1.00
[M + H]+ [M+HCOO]–
LPC 14:0 468.3085 512.2997 0.00 0.56 3.27 1.26
LPC 15:0 526.3154 0.74 1.21 0.31
LPC 16:0 496.3397 540.3309 -0.05 0.38 185.80 54.27
LPC 16:1 494.3241 538.3151 0.00 0.18 5.01 1.73
LPC 17:0 554.3465 0.33 2.34 0.80
LPC 18:0 524.3709 568.3623 -0.23 0.50 50.53 16.01
LPC 18:1 522.3554 566.3466 -0.09 0.52 42.39 13.56
LPC 18:2 520.3394 564.3311 -0.69 0.63 55.61 15.14
LPC 18:3 562.3153 0.54 0.75 0.37
LPC 20:3 546.3562 590.3466 1.48 0.35 3.62 1.16
LPC 20:4 544.3400 588.3309 0.49 0.43 11.70 5.16
LPC 20:5 586.3152 -0.10 0.33 1.30 1.06
LPC 22:6 568.3401 612.3308 0.51 0.12 2.17 1.23
[M + H]+ [M+HCOO]–
LPC-O 16:0 482.3605 526.3518 -0.06 0.75 0.60 0.26
LPC-O 16:1 480.3449 524.3360 0.08 0.45 0.64 0.35
LPC-O 18:1 508.3761 552.3672 -0.09 0.19 0.46 0.24
[M + NH4]
+ [M−H]–
PI 34:1 835.5348 0.69 3.87 2.34
PI 34:2 852.5605 833.5190 0.96 0.48 2.66 1.80
PI 36:1 863.5655 0.04 3.86 1.66
PI 36:2 880.5915 861.5500 0.65 0.17 10.91 5.99
PI 36:3 878.5768 859.5346 1.75 0.48 1.63 0.59
PI 36:4 857.5188 0.32 3.52 1.81
PI 38:4 904.5915 885.5498 0.59 -0.04 36.83 14.59
PI 40:6 909.5489 -1.07 1.43 1.01
[M + H]+ [M−H]–
PS 36:1 788.5457 1.22 1.14 0.57
PS 38:2 814.5607 0.41 0.19 0.09
PS 38:3 812.5444 0.94 0.40 0.20
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Table A-3: Composition of standard mixture for lipid quantiﬁcation in rat
retina by HCD FT MS/MS. – The concentration of lipid standards (impurities < 1 %)
is speciﬁed for aliquots of the extraction mixture (V = 1 ml MTBE/MeOH (v:v – 10:3)).
Standard Concentration,  M
PC 17:0/17:0 10.8
PE 17:0/17:0 9.3
PS 12:0/12:0 9.5
PI 8:0/8:0 10.1
Table A-4: Content of molecular lipid species in rat retina. – Values are reported
as average and SD of 4 experiments.
Lipid specie Average content, Standard deviation,
pmol/mg pmol/mg
PC 14:0/16:0 69.07 7.63
PC 14:0/18:0 13.84 4.88
PC 16:0/16:0 2529.25 190.10
PC 16:0/18:0 1029.98 39.14
PC 16:0/18:1 3073.91 192.72
PC 16:0/18:2 74.86 8.18
PC 16:0/20:1 62.68 7.02
PC 16:0/20:2 57.36 7.26
PC 16:0/20:4 668.58 114.26
PC 16:0/20:5 2.94 0.91
PC 16:0/22:4 46.92 9.76
PC 16:0/22:6 1234.39 188.63
PC 16:0/24:4 4.70 0.95
PC 16:0/24:6 21.91 2.70
PC 16:0/26:4 0.51 0.18
PC 16:0/26:5 0.95 0.30
PC 16:0/26:6 1.42 0.30
PC 16:0/32:6 11.75 0.58
PC 16:0/34:6 6.53 1.03
PC 16:1/16:0 149.28 11.45
PC 16:1/16:1 1.79 1.25
PC 16:1/18:0 35.21 2.87
PC 16:1/18:1 22.65 7.55
PC 16:1/20:4 4.48 1.10
PC 16:2/16:0 5.33 2.05
PC 16:2/18:0 0.78 0.26
PC 18:0/20:2 238.76 27.20
PC 18:0/20:4 872.79 61.44
PC 18:0/22:4 62.04 4.47
PC 18:0/22:6 3599.40 757.59
PC 18:0/24:4 17.51 1.22
PC 18:0/24:5 32.80 0.92
PC 18:0/24:6 38.49 6.14
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Lipid specie Average content, Standard deviation,
pmol/mg pmol/mg
PC 18:0/26:6 3.61 0.27
PC 18:0/32:6 1.92 0.28
PC 18:1/18:0 1223.31 157.17
PC 18:1/18:1 180.37 9.16
PC 18:1/20:0 1.18 0.23
PC 18:1/20:1 9.70 2.05
PC 18:1/20:3 5.66 0.70
PC 18:1/22:6 147.15 11.31
PC 18:1/24:4 0.97 0.28
PC 18:1/24:5 1.36 0.29
PC 18:1/24:6 1.66 0.21
PC 18:1/32:6 2.10 0.12
PC 18:1/34:6 1.56 0.03
PC 18:2/18:0 40.94 2.72
PC 18:2/18:2 2.14 0.61
PC 20:1/22:4 0.36 0.13
PC 20:2/20:2 0.89 0.36
PC 20:4/22:6 79.88 3.82
PC 20:4/24:6 2.65 0.64
PC 20:4/32:6 7.69 0.08
PC 20:4/34:5 1.77 0.16
PC 20:4/34:6 5.06 0.13
PC 22:4/24:6 0.24 0.16
PC 22:6/22:4 59.12 7.74
PC 22:6/22:6 1545.55 218.00
PC 22:6/24:4 12.56 0.65
PC 22:6/24:5 19.55 1.09
PC 22:6/24:6 92.12 7.07
PC 22:6/26:4 5.88 3.95
PC 22:6/26:5 13.60 0.76
PC 22:6/26:6 25.13 1.52
PC 22:6/28:6 22.96 1.98
PC 22:6/30:4 7.98 1.16
PC 22:6/30:5 9.07 0.99
PC 22:6/30:6 26.64 2.18
PC 22:6/32:4 23.76 1.54
PC 22:6/32:5 23.60 2.60
PC 22:6/32:6 417.53 43.04
PC 22:6/34:5 43.49 5.23
PC 22:6/34:6 312.99 21.82
PC 22:6/36:6 28.14 4.02
PC 24:6/24:6 0.38 0.06
PC 24:6/32:6 1.84 0.46
PC 24:6/34:6 1.31 0.07
PC-O 16:1/20:4 36.93 3.30
PC-O 18:1/20:4 27.68 2.87
PC-O 18:1/22:6 517.28 39.60
PE 14:0/22:4 0.37 0.11
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Lipid specie Average content, Standard deviation,
pmol/mg pmol/mg
PE 16:0/18:0 68.69 3.42
PE 16:0/18:1 83.27 15.64
PE 16:0/20:1 23.42 1.37
PE 16:0/20:2 3.19 0.09
PE 16:0/20:4 130.02 81.13
PE 16:0/22:4 37.86 7.49
PE 16:0/22:6 1653.18 87.10
PE 16:0/24:4 9.31 0.97
PE 16:0/26:6 5.59 0.84
PE 16:1/18:0 8.77 0.81
PE 16:1/20:1 0.80 0.26
PE 16:1/20:3 0.72 0.40
PE 16:1/22:4 2.77 0.65
PE 16:1/24:6 0.39 0.29
PE 18:0/18:1 248.06 5.84
PE 18:0/18:2 13.85 1.56
PE 18:0/20:2 5.18 0.22
PE 18:0/20:4 1506.51 161.66
PE 18:0/20:5 8.85 1.22
PE 18:0/22:4 220.07 52.97
PE 18:0/22:6 8920.62 347.09
PE 18:0/24:4 6.23 0.49
PE 18:0/24:5 8.22 0.76
PE 18:0/24:6 31.58 3.17
PE 18:1/18:1 25.50 2.59
PE 18:1/20:1 6.33 0.31
PE 18:1/20:3 2.93 0.94
PE 18:1/20:4 115.67 17.64
PE 18:1/20:5 18.25 5.56
PE 18:1/22:5 9.95 6.93
PE 18:1/22:6 515.90 25.71
PE 18:1/24:4 2.86 0.47
PE 18:1/24:5 7.72 1.26
PE 18:1/24:6 3.10 0.30
PE 18:2/18:2 3.89 1.81
PE 18:2/20:3 0.46 0.25
PE 18:2/20:4 16.01 1.39
PE 18:2/22:5 0.99 0.48
PE 18:2/22:6 112.24 6.40
PE 20:0/22:5 2.05 0.49
PE 20:1/22:4 2.17 0.42
PE 20:1/22:6 66.93 14.15
PE 20:2/22:6 49.72 3.32
PE 20:3/22:4 0.27 0.15
PE 20:4/20:4 2.83 0.15
PE 20:4/22:3 5.46 0.55
PE 20:4/22:4 8.51 0.30
PE 20:4/22:6 482.68 27.14
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Lipid specie Average content, Standard deviation,
pmol/mg pmol/mg
PE 20:4/24:6 5.35 0.55
PE 20:5/22:6 18.71 2.82
PE 22:6/22:4 114.48 2.27
PE 22:6/22:6 2017.10 452.62
PE 22:6/24:4 92.23 12.50
PE 22:6/24:6 177.28 6.58
PE-O 16:0/20:4 24.59 1.69
PE-O 16:0/22:5 3.84 1.70
PE-O 16:0/22:6 112.28 8.56
PE-O 16:1/16:0 27.83 2.46
PE-O 16:1/18:1 30.63 23.05
PE-O 16:1/20:1 1.13 0.34
PE-O 16:1/20:3 1.93 0.34
PE-O 16:1/20:4 212.19 11.21
PE-O 16:1/22:4 71.63 18.90
PE-O 16:1/22:5 21.84 4.69
PE-O 16:1/22:6 738.33 23.17
PE-O 16:1/24:5 2.77 0.48
PE-O 18:0/24:6 0.93 0.41
PE-O 18:1/16:0 44.98 7.09
PE-O 18:1/16:1 4.73 3.25
PE-O 18:1/18:1 102.68 14.78
PE-O 18:1/18:2 15.36 5.12
PE-O 18:1/20:4 1320.90 136.80
PE-O 18:1/20:5 10.99 1.61
PE-O 18:1/22:5 64.89 12.62
PE-O 18:1/22:6 1786.63 74.55
PE-O 18:1/24:5 8.45 2.17
PE-O 18:1/24:6 12.20 0.98
PE-O 18:2/16:0 17.66 13.04
PE-O 18:2/18:1 80.52 10.52
PE-O 18:2/20:3 2.87 0.97
PE-O 18:2/20:4 319.89 21.97
PE-O 18:2/20:5 2.32 0.44
PE-O 18:2/22:4 11.75 2.74
PE-O 18:2/22:5 7.03 2.43
PE-O 18:2/22:6 252.49 9.97
PE-O 18:2/24:4 0.36 0.09
PE-O 18:2/24:5 0.79 0.02
PE-O 18:2/24:6 1.42 0.07
PE-O 18:3/20:4 22.11 2.07
PE-O 20:1/22:6 23.04 2.06
PE-O 20:2/20:4 13.20 3.51
PE-O 20:2/22:4 1.90 0.48
PE-O 20:2/22:5 0.59 0.25
PE-O 20:2/22:6 19.02 5.22
PI 16:0/20:4 372.62 70.11
PI 16:0/22:6 70.44 35.37
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Lipid specie Average content, Standard deviation,
pmol/mg pmol/mg
PI 18:0/20:4 1141.40 125.85
PI 18:0/20:5 9.46 2.22
PI 18:0/22:4 2.53 0.60
PI 18:0/22:5 4.80 2.99
PI 18:1/20:4 97.04 25.81
PI 18:1/22:4 8.17 4.48
PI 18:2/20:4 10.64 1.50
PI 20:4/20:1 9.97 1.23
PI 20:4/22:6 21.06 4.61
PS 16:0/18:1 1.53 0.41
PS 16:0/20:2 0.06 0.02
PS 16:0/20:4 0.84 0.20
PS 16:0/22:6 3.89 0.44
PS 16:1/18:0 0.34 0.05
PS 16:1/20:3 0.08 0.02
PS 16:1/22:5 0.03 0.01
PS 18:0/20:4 81.93 13.01
PS 18:0/20:5 0.69 0.08
PS 18:0/22:6 826.00 150.16
PS 18:0/24:6 0.44 0.07
PS 18:1/18:0 6.99 0.98
PS 18:1/18:1 0.91 0.13
PS 18:1/20:4 0.92 0.10
PS 18:1/20:5 0.08 0.02
PS 18:2/18:0 0.90 0.14
PS 18:2/18:2 0.03 0.00
PS 20:0/22:6 2.02 0.27
PS 20:4/22:6 6.41 1.02
PS 22:6/22:4 43.96 9.31
PS 22:6/22:6 445.83 41.41
PS 22:6/24:5 31.76 5.98
PS 22:6/24:6 85.80 21.12
PS 22:6/26:6 2.84 0.94
PS 24:6/24:6 0.05 0.03
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Table A-5: Alteration of blood plasma lipids by size exclusion apheresis. –
Blood plasma of a patient was analyzed by shotgun lipidomics. Lipid concentrations are
speciﬁed by the average and SD of 2 technical replicates.
Lipid Concentration,  M
class before directly after 3 d after
LDL apheresis
CholE 3419.1 ± 54.6 970.3 ± 16.1 1626.8 ± 18.4
Chol 1160.2 ± 301.8 294.0 ± 90.3 987.5 ± 516.8
TAG 435.0 ± 26.8 119.9 ± 4.1 348.34 ± 9.2
DAG 19.5 ± 0.7 4.0 ± 0.5 11.5 ± 0.8
PC 1055.0 ± 12.0 463.7 ± 61.9 779.2 ± 9.0
PC-O 38.3 ± 1.7 11.7 ± 1.5 29.4 ± 2.2
LPC 236.9 ± 3.3 124.8 ± 20.7 196.6 ± 3.7
LPC-O 0.6 ± 0.1 0.0 ± 0.0 0.1 ± 0.1
PE 14.2 ± 0.7 11.0 ± 1.9 15.0 ± 0.5
PE-O 12.9 ± 0.9 6.8 ± 1.3 14.3 ± 0.9
LPE 9.3 ± 0.4 12.0 ± 2.1 12.3 ± 0.4
PI 28.2 ± 0.7 10.9 ± 1.3 18.1 ± 1.0
SM 194.6 ± 4.1 42.3 ± 3.8 85.6 ± 3.0
Cer 2.9 ± 0.3 0.5 ± 0.1 1.5 ± 0.1
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Table A-6: Lipid concentration in the blood plasma of NGT, IGT and T2D
subjects. – The lipid class concentration was determined by summation of the concen-
tration of the individual lipid species determined by FT MS measurements. Values are
reported by the average and SEM per group.
Lipid Group 1 Group 2 Group 3
class
CholE 7340.7 ± 328.5 6112.4 ± 198.0 5772.3 ± 244.3
Chol 1764.3 ± 118.9 1522.5 ± 90.1 1577.5 ± 73.6
TAG 2671.2 ± 573.4 2288.3 ± 415.5 3215.3 ± 634.0
DAG 110.1 ± 20.5 103.3 ± 16.8 131.8 ± 19.4
Cer 7.1 ± 0.7 5.5 ± 0.4 6.1 ± 0.6
PE 63.3 ± 7.9 60.0 ± 2.9 59.4 ± 5.5
PE-O 33.8 ± 2.3 29.6 ± 1.6 25.1 ± 2.3
PI 70.6 ± 5.4 67.4 ± 4.4 72.0 ± 6.8
PC 2752.0 ± 143.8 2715.7 ± 113.6 2522.4 ± 176.6
PC-O 114.6 ± 5.6 101.2 ± 4.2 83.7 ± 6.8
SM 503.5 ± 20.7 454.8 ± 14.6 440.2 ± 19.4
LPC 338.0 ± 22.1 306.3 ± 13.6 256.8 ± 30.6
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Table A-7: Anthropometric and biochemical characteristics of NGT, IGT, and
T2D male subjects. – Blood plasma samples were obtained for time points −1 min and
120 min; before and after oral glucose challenge. Measured data are represented by the
average and SEM per group. P-values are given for signiﬁcant diﬀerences (p < 0.05).
Control IGT T2D p-values
Control/IGT Control/T2D
N 20 20 16
Age, y 44 ± 3 61 ± 3 59 ± 2 < 0.001 0.001
BMI, kg/m2 28.0 ± 0.9 27.7 ± 0.6 29.9 ± 0.5
WHtR, [] 0.54 ± 0.01 0.58 ± 0.01 0.62 ± 0.04 < 0.001
TC, mM 5.43 ± 0.26 5.00 ± 0.20 5.39 ± 0.21
TG, mM 2.23 ± 0.45 2.03 ± 0.35 2.69 ± 0.41
HDL-C, mM 1.29 ± 0.07 1.29 ± 0.09 1.11 ± 0.06
LDL-C, mM 3.35 ± 0.18 2.93 ± 0.15 3.28 ± 0.19
HbA1c, % 5.2 ± 0.1 5.7 ± 0.1 6.3 ± 0.1 0.003 < 0.001
Plasma glucose, mM
-1 min 5.24 ± 0.09 5.64 ± 0.15 6.86 ± 0.23 < 0.001
120 min 5.23 ± 0.26 8.96 ± 0.25 11.32 ± 0.73 < 0.001 < 0.001
FFA, mM
-1 min 0.45 ± 0.03 0.49 ± 0.03 0.57 ± 0.05
120 min 0.08 ± 0.01 0.07 ± 0.01 0.09 ± 0.01
Insulin, pM
-1 min 70.0 ± 7.1 67.7 ± 11.0 138.7 ± 24.5
120 min 182.9 ± 29.5 560.9 ± 62.0 569.6 ± 81.5 < 0.001 < 0.001
C-peptide, pM
-1 min 724 ± 52 888 ± 46 1397 ± 181 < 0.001
120 min 2357 ± 177 3971 ± 301 3485 ± 235 < 0.001
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Table A-8: Anthropometric and biochemical characteristics of male subjects
with distinct FABP4 blood plasma level. – Measured data are represented by the
average and SD per group. P-values are given for signiﬁcant diﬀerences (p < 0.05).
Group I Group II p-value
N 6 6
Age, y 52.2 ± 11.3 43.7 ± 18.9
BMI, kg/m 32.4 ± 3.7 36.7 ± 7.5
WHR, [] 1.1 ± 0.1 1.0 ± 0.1
Body fat, % 26.5 ± 4.4 33.6 ± 8.8
TC, mM 5.2 ± 0.5 5.3 ± 1.3
TG, mM 1.3 ± 0.4 2.0 ± 0.9
FFA, mM 0.5 ± 0.3 0.7 ± 0.5
HDL-C, mM 1.4 ± 0.4 1.0 ± 0.1
LDL-C, mM 3.4 ± 0.6 3.6 ± 1.3
FABP4, ng/ml 13.4 ± 2.9 23.4 ± 3.0 2.0×10−4
hsCRP, mg/dl 2.1 ± 1.5 2.6 ± 1.1
C-Peptid, nM 1.2 ± 0.6 1.4 ± 0.7
HbA1c, % 5.6 ± 0.3 5.7 ± 0.2
Insulin, pM 147.0 ± 97.5 176.9 ± 140.2
Plasma glucose, OGTT, mM
-1 min 5.6 ± 0.4 5.6 ± 0.4
120 min 6.4 ± 1.3 6.8 ± 1.5
WBG, mol/kg/min 73.5 ± 24.0 66.8 ± 24.1
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Figure A-1: FT MS/MS spectra of intense background compounds. – Spec-
tra were acquired by direct infusion on LTQ Orbitrap XL. The measured sample com-
prised isopropanol/methanol/chloroform (v:v:v – 4:2:1) with 7.5 mM ammonium acetate.
Abundant and speciﬁc fragments of background components have been assigned. (A)
13-docosenoamide ([M + H]+); (B) nonaethylene glycol ([M + NH4]
+); (C) octadecyl (di-
tert-butyl-hydroxyphenyl)propionate ([M + NH4]
+); (D) tris(di-tert-butylphenyl) phos-
phite ([M + H]+); (E) Pentaerythritol tetrakis((di-tert-butyl-hydroxyphenyl)propionate)
([M + NH4]
+)
128
Acknowledgements
I would like to acknowledge my advisors Prof. Dr. Stefan R. Bornstein
and Dr. Andrej Shevchenko for their trust and motivation, for providing
facilities and building connections, and for their scientiﬁc input.
I am very grateful to Prof. Dr. Brigitte Voit for reviewing my thesis.
I am indebted to my colleages and collaborators: Prof. Dr. Ju¨rgen Gra¨ssler,
Dr. Barbara Ludwig, Dr. Valeria Zepter, Dr. Steﬃ Kopprasch, Sigrid
Nitzsche (Medizinische Klinik und Poliklinik III, Dresden); Ronny Herzog,
Dr. Henrik Thomas, Dr. Marc Gentzel, Dr. Julio L. Sampaio, Dr. Christian
Klose, Dr. Susanne Sales (Shevchenko group, MPI-CBG, Dresden); Dr.
Sider Penkov (MPI-CBG, Dresden), Dr. Dominik Schwudke (NCBI, India);
Dr. Christer Ejsing (SDU, Denmark) for their active or kind support.
Further, I have to acknowledge Dr. Wolfgang Metelmann-Strupat, Dr.
Markus Kellmann (Thermo Fisher Scientiﬁc), Reinaldo Almeida, Mark Bau-
mert (Advion BioSciences) and Dr. Bradley Schneider (ABSciex) for the
interesting and productive co-operation.
Erkla¨rung entsprechend  5.5 der Promotionsordnung
Hiermit versichere ich, dass ich die vorliegende Arbeit ohne unzula¨ssige Hilfe
Dritter und ohne Benutzung anderer als der angegebenen Hilfsmittel ange-
fertigt habe; die aus fremden Quellen direkt oder indirekt u¨bernommenen
Gedanken sind als solche kenntlich gemacht. Die Arbeit wurde bisher weder
im Inland noch im Ausland in gleicher oder a¨hnlicher Form einer anderen
Pru¨fungsbeho¨rde vorgelegt.
Die Dissertation wurde im Zeitraum vom April 2008 bis April 2012 verfasst
und von Prof. Dr. Stefan R. Bornstein, Universita¨tsklinikum Carl Gustav
Carus, Medizinische Klinik und Poliklinik III betreut.
Meine Person betreﬀend erkla¨re ich hiermit, dass keine fru¨heren erfolglosen
Promotionsverfahren stattgefunden haben.
Ich erkenne die Promotionsordnung der Fakulta¨t fu¨r Mathematik und Natur-
wissenschaften, Technische Universita¨t Dresden an.
